☰

Caryn Lerman - Publications

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 
Area:
Nicotine, Pharmacology, Public Health
Website:
http://www.med.upenn.edu/apps/faculty/index.php/g275/p11960
Tree Info Similar researchers PubMed Report error

256/404 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Chenoweth MJ, Kim YJ, Nollen NL, Hawk LW, Mahoney MC, Lerman C, Knight J, Tyndale RF. Genetic Prediction of Smoking Cessation Medication Side Effects: A Genome-Wide Investigation of Abnormal Dreams on Varenicline. Clinical Pharmacology and Therapeutics. PMID 38369951 DOI: 10.1002/cpt.3210  0.318
2023 Wanger TJ, de Moura FB, Ashare R, Loughead J, Lukas S, Lerman C, Janes AC. Brain and cortisol responses to smoking cues are linked in tobacco-smoking individuals. Addiction Biology. 28: e13338. PMID 38017638 DOI: 10.1111/adb.13338  0.361
2023 Giratallah H, Chenoweth MJ, Pouget JG, El-Boraie A, Alsaafin A, Lerman C, Knight J, Tyndale RF. CYP2A6 associates with respiratory disease risk and younger age of diagnosis: a phenome-wide association Mendelian randomization study. Human Molecular Genetics. PMID 37802914 DOI: 10.1093/hmg/ddad172  0.303
2023 Truong VTT, Green C, Pedroza C, Hwang LY, Rajan SS, Suchting R, Cinciripini P, Tyndale RF, Lerman C. Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy. Bmc Medical Research Methodology. 23: 107. PMID 37118656 DOI: 10.1186/s12874-023-01931-7  0.347
2023 Chenoweth MJ, Lerman C, Knight J, Tyndale RF. Influence of CYP2A6 genetic variation, nicotine dependence severity, and treatment on smoking cessation success. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 36789481 DOI: 10.1093/ntr/ntac268  0.453
2022 Han DH, Cho J, Harlow AF, Tackett AP, Vogel EA, Wong M, Barrington-Trimis JL, Lerman C, Unger JB, Leventhal AM. Young adults' beliefs about modern oral nicotine products: Implications for uptake in nonvapers, dual use with e-cigarettes, and use to reduce/quit vaping. Experimental and Clinical Psychopharmacology. PMID 36048111 DOI: 10.1037/pha0000595  0.323
2022 Lerman C, Hughes-Halbert C, Falcone M, Gosky DM, Jensen RA, Lee KP, Mitchell E, Odunsi K, Pegher JW, Rodriguez E, Sanchez Y, Shaw R, Weiner G, Willman CL. Leadership Diversity and Development in the Nation's Cancer Centers. Journal of the National Cancer Institute. PMID 35897143 DOI: 10.1093/jnci/djac121  0.686
2022 Vogel EA, Barrington-Trimis JL, Kechter A, Tackett AP, Liu F, Sussman S, Lerman C, Unger JB, Hughes Halbert C, Chaffee BW, Leventhal AM. Differences in Young Adults' Perceptions of and Willingness to Use Nicotine Pouches by Tobacco Use Status. International Journal of Environmental Research and Public Health. 19. PMID 35270385 DOI: 10.3390/ijerph19052685  0.326
2022 Giannoulis SV, Chenoweth MJ, Saquilayan P, Tyndale RF, Lerman C, Kennedy JL, Zawertailo L, Gonçalves V. Examining the role of mitochondrial genetic variation in nicotine dependence. Psychiatry Research. 310: 114452. PMID 35227992 DOI: 10.1016/j.psychres.2022.114452  0.349
2021 Balfour DJK, Benowitz NL, Colby SM, Hatsukami DK, Lando HA, Leischow SJ, Lerman C, Mermelstein RJ, Niaura R, Perkins KA, Pomerleau OF, Rigotti NA, Swan GE, Warner KE, West R. Balancing Consideration of the Risks and Benefits of E-Cigarettes. American Journal of Public Health. e1-e12. PMID 34410826 DOI: 10.2105/AJPH.2021.306416  0.345
2021 Giratallah HK, Chenoweth MJ, Addo N, Ahluwalia JS, Cox LS, Lerman C, George TP, Benowitz NL, Tyndale RF. Nicotine metabolite ratio: Comparison of the three urinary versions to the plasma version and nicotine clearance in three clinical studies. Drug and Alcohol Dependence. 223: 108708. PMID 33873029 DOI: 10.1016/j.drugalcdep.2021.108708  0.354
2021 Schnoll R, Paul Wileyto E, Bauer AM, Fox E, Leone F, Lerman C, Tyndale RF, George TP, Hawk L, Cinciripini P, Quinn M, Purnell J, Hatzell J, Hitsman B. Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder. The American Journal On Addictions. PMID 33772971 DOI: 10.1111/ajad.13155  0.38
2021 Chenoweth MJ, Lerman C, Knight J, Tyndale RF. A genome-wide association study of nausea incidence in varenicline-treated cigarette smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 33713409 DOI: 10.1093/ntr/ntab044  0.355
2021 Falcone M, Liu L, Farias A, Zhang J, Kang I, Li M, Stern MC, Lerman C. Evidence for racial/ethnic disparities in emergency department visits following breast cancer surgery among women in California: a population-based study. Breast Cancer Research and Treatment. PMID 33675489 DOI: 10.1007/s10549-021-06119-5  0.679
2020 El-Boraie A, Chenoweth MJ, Pouget JG, Benowitz NL, Fukunaga K, Mushiroda T, Kubo M, Nollen NL, Cox LS, Lerman C, Knight J, Tyndale RF. Transferability Of Ancestry-Specific And Cross-Ancestry CYP2A6 Activity Genetic Risk Scores In African And European Populations. Clinical Pharmacology and Therapeutics. PMID 33300144 DOI: 10.1002/cpt.2135  0.302
2020 Falcone M, Luo C, Chen Y, Birtwell D, Cheatle M, Duan R, Gabriel PE, He L, Ko EM, Lenz HJ, Mirkovic N, Mowery DL, Ochroch EAA, Paulson ECC, Schriver E, ... ... Lerman C, et al. Risk of persistent opioid use following major surgery in matched samples of patients with and without cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32859580 DOI: 10.1158/1055-9965.Epi-20-0628  0.694
2020 Ashare RL, Wileyto EP, Logue-Chamberlain E, Gross R, Tyndale RF, Lerman C, Hawk LW, Cinciripini P, George TP, Lubitz SF, Schnoll R. Patterns of lapses and recoveries during a quit attempt using varenicline and behavioral counseling among smokers with and without HIV. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 32686950 DOI: 10.1037/Adb0000619  0.312
2020 Schnoll R, Paul Wileyto E, Gross R, Hitsman B, Hawk LW, Cinciripini P, George TP, Benowitz NL, Fen Lubitz S, Ashare R, Tyndale RF, Lerman C. Evaluation of nicotine patch adherence measurement using self-report and saliva cotinine among abstainers in a smoking cessation trial. Drug and Alcohol Dependence. 210: 107967. PMID 32224420 DOI: 10.1016/J.Drugalcdep.2020.107967  0.477
2020 Buchwald J, Chenoweth MJ, Palviainen T, Zhu G, Benner C, Gordon S, Korhonen T, Ripatti S, Madden PAF, Lehtimäki T, Raitakari OT, Salomaa V, Rose RJ, George TP, Lerman C, et al. Genome-wide association meta-analysis of nicotine metabolism and cigarette consumption measures in smokers of European descent. Molecular Psychiatry. PMID 32157176 DOI: 10.1038/S41380-020-0702-Z  0.516
2020 Siegel SD, Lerman C, Flitter A, Schnoll RA. The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions. Cancer Prevention Research (Philadelphia, Pa.). 13: 261-272. PMID 32132120 DOI: 10.1158/1940-6207.Capr-19-0259  0.531
2020 Cheatle MD, Falcone M, Dhingra L, Lerman C. Independent association of tobacco use with opioid use disorder in patients of European ancestry with chronic non-cancer pain. Drug and Alcohol Dependence. 209: 107901. PMID 32126454 DOI: 10.1016/J.Drugalcdep.2020.107901  0.712
2019 Frank DW, Cinciripini PM, Deweese MM, Karam-Hage M, Kypriotakis G, Lerman C, Robinson JD, Tyndale RF, Vidrine DJ, Versace F. Toward Precision Medicine for Smoking Cessation: Developing a Neuroimaging-Based Classification Algorithm to Identify Smokers at Higher Risk for Relapse. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31724052 DOI: 10.1093/Ntr/Ntz211  0.464
2019 Peng AR, Swardfager W, Benowitz NL, Ahluwalia JS, Lerman C, Nollen NL, Tyndale RF. Impact of Early Nausea on Varenicline Adherence and Smoking Cessation. Addiction (Abingdon, England). PMID 31502736 DOI: 10.1111/Add.14810  0.467
2019 Chen J, Loukola A, Gillespie NA, Peterson R, Jia P, Riley B, Maes H, Dick DM, Kendler KS, Damaj MI, Miles MF, Zhao Z, Li MD, Vink JM, Minica CC, ... ... Lerman C, et al. Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31294817 DOI: 10.1093/Ntr/Ntz099  0.471
2019 Allenby C, Falcone M, Ashare RL, Cao W, Bernardo L, Wileyto EP, Pruessner J, Loughead J, Lerman C. Brain Marker Links Stress and Nicotine Abstinence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31120113 DOI: 10.1093/Ntr/Ntz077  0.739
2019 Ashare RL, Thompson M, Leone F, Metzger D, Gross R, Mounzer K, Tyndale RF, Lerman C, Mahoney MC, Cinciripini P, George TP, Collman RG, Schnoll R. Differences in the rate of nicotine metabolism among smokers with and without HIV. Aids (London, England). 33: 1083-1088. PMID 30946162 DOI: 10.1097/Qad.0000000000002127  0.432
2019 El-Boraie A, Taghavi T, Chenoweth MJ, Fukunaga K, Mushiroda T, Kubo M, Lerman C, Nollen NL, Benowitz NL, Tyndale RF. Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity. Addiction Biology. PMID 30815984 DOI: 10.1111/Adb.12741  0.455
2019 Allenby C, Falcone M, Wileyto EP, Cao W, Bernardo L, Ashare RL, Janes A, Loughead J, Lerman C. Neural cue reactivity during acute abstinence predicts short-term smoking relapse. Addiction Biology. PMID 30806013 DOI: 10.1111/Adb.12733  0.793
2019 Ashare RL, Thompson M, Leone F, Metzger D, Gross R, Mounzer K, Tyndale RF, Lerman C, Mahoney MC, Cinciripini P, George TP, Collman RG, Schnoll R. Differences in the rate of nicotine metabolism among smokers with and without HIV. Aids (London, England). PMID 30649060 DOI: 10.1097/QAD.0000000000002127  0.32
2019 Robinson JD, Li L, Chen M, Lerman C, Tyndale RF, Schnoll RA, Hawk LW, George TP, Benowitz NL, Cinciripini PM. Evaluating the temporal relationships between withdrawal symptoms and smoking relapse. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 30614717 DOI: 10.1037/Adb0000434  0.484
2019 Falcone M, Bernardo L, Wileyto EP, Allenby C, Burke AM, Hamilton R, Cristancho M, Ashare RL, Loughead J, Lerman C. Lack of effect of transcranial direct current stimulation (tDCS) on short-term smoking cessation: Results of a randomized, sham-controlled clinical trial. Drug and Alcohol Dependence. 194: 244-251. PMID 30497056 DOI: 10.1016/J.Drugalcdep.2018.10.016  0.763
2019 Peng AR, Schnoll R, Lerman C, Tyndale RF. Different measures of varenicline adherence, nicotine metabolite ratio and smoking abstinence Drug Metabolism and Pharmacokinetics. 34: S16-S17. DOI: 10.1016/J.Dmpk.2018.09.077  0.52
2018 Mercincavage M, Lochbuehler K, Wileyto EP, Benowitz NL, Tyndale RF, Lerman C, Strasser AA. Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers: A Nonrandomized Clinical Trial. Jama Network Open. 1. PMID 30627706 DOI: 10.1001/jamanetworkopen.2018.1346  0.425
2018 To C, Falcone M, Loughead J, Logue-Chamberlain E, Hamilton R, Kable J, Lerman C, Ashare RL. Got chocolate? Bilateral prefrontal cortex stimulation augments chocolate consumption. Appetite. 131: 28-35. PMID 30171915 DOI: 10.1016/J.Appet.2018.08.032  0.695
2018 Peng AR, Schnoll R, Hawk LW, Cinciripini P, George TP, Lerman C, Tyndale RF. Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes. Drug and Alcohol Dependence. 190: 72-81. PMID 29986268 DOI: 10.1016/J.Drugalcdep.2018.04.035  0.37
2018 Allenby C, Falcone M, Bernardo L, Wileyto EP, Rostain A, Ramsay JR, Lerman C, Loughead J. Transcranial direct current brain stimulation decreases impulsivity in ADHD. Brain Stimulation. PMID 29885858 DOI: 10.1016/J.Brs.2018.04.016  0.7
2018 Taghavi T, Novalen M, Lerman C, George TP, Tyndale RF. A comparison of direct and indirect analytical approaches to measuring total nicotine equivalents in urine. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29853480 DOI: 10.1158/1055-9965.Epi-18-0018  0.378
2018 Tanner JA, Zhu AZ, Claw KG, Prasad B, Korchina V, Hu J, Doddapaneni H, Muzny DM, Schuetz EG, Lerman C, Thummel KE, Scherer SE, Tyndale RF. Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism. Pharmacogenetics and Genomics. 28: 7-16. PMID 29232328 DOI: 10.1097/Fpc.0000000000000317  0.447
2017 Chenoweth MJ, Ware JJ, Zhu AZX, Cole CB, Cox LS, Nollen N, Ahluwalia JS, Benowitz NL, Schnoll RA, Hawk LW, Cinciripini PM, George TP, Lerman C, Knight J, Tyndale RF, et al. Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences. Addiction (Abingdon, England). PMID 28921760 DOI: 10.1111/Add.14032  0.484
2017 Peng AR, Morales M, Wileyto EP, Hawk LW, Cinciripini P, George TP, Benowitz NL, Nollen NL, Lerman C, Tyndale RF, Schnoll R. Measures and predictors of varenicline adherence in the treatment of nicotine dependence. Addictive Behaviors. 75: 122-129. PMID 28728040 DOI: 10.1016/J.Addbeh.2017.07.006  0.416
2017 Kable JW, Caulfield MK, Falcone M, McConnell M, Bernardo L, Parthasarathi T, Cooper N, Ashare R, Audrain-McGovern J, Hornik R, Diefenbach P, Lee FJ, Lerman C. No Effect of Commercial Cognitive Training on Neural Activity During Decision-Making. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28694338 DOI: 10.1523/Jneurosci.2832-16.2017  0.702
2017 Ashare RL, Lerman C, Tyndale RF, Hawk LW, George TP, Cinciripini P, Schnoll RA. Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment? Journal of Smoking Cessation. 12: 63-70. PMID 28553407 DOI: 10.1017/Jsc.2016.11  0.376
2016 Loughead J, Falcone M, Wileyto EP, Albelda B, Audrain-McGovern J, Cao W, Kurtz MM, Gur RC, Lerman C. Can brain games help smokers quit?: Results of a randomized clinical trial. Drug and Alcohol Dependence. 168: 112-118. PMID 27635998 DOI: 10.1016/J.Drugalcdep.2016.08.621  0.783
2016 Rabin RA, Ashare RL, Schnoll RA, Cinciripini PM, Hawk LW, Lerman C, Tyndale RF, George TP. Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 27187893 DOI: 10.1111/Ajad.12382  0.5
2016 Ross KC, Gubner NR, Tyndale RF, Hawk LW, Lerman C, George TP, Cinciripini P, Schnoll RA, Benowitz NL. Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking. Pharmacology, Biochemistry, and Behavior. PMID 27180107 DOI: 10.1016/J.Pbb.2016.05.002  0.465
2016 Ashare RL, Lerman C, Cao W, Falcone M, Bernardo L, Ruparel K, Hopson R, Gur R, Pruessner JC, Loughead J. Nicotine withdrawal alters neural responses to psychosocial stress. Psychopharmacology. PMID 27087432 DOI: 10.1007/S00213-016-4299-5  0.757
2016 Falcone M, Lee B, Lerman C, Blendy JA. Translational Research on Nicotine Dependence. Current Topics in Behavioral Neurosciences. PMID 26873019 DOI: 10.1007/7854_2015_5005  0.767
2016 Allenby CE, Boylan KA, Lerman C, Falcone M. Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 11: 471-83. PMID 26872457 DOI: 10.1007/S11481-016-9656-Y  0.811
2015 Falcone M, Cao W, Bernardo L, Tyndale RF, Loughead J, Lerman C. Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism Rate. Biological Psychiatry. PMID 26805583 DOI: 10.1016/J.Biopsych.2015.11.015  0.802
2015 Falcone M, Bernardo L, Ashare RL, Hamilton R, Faseyitan O, McKee SA, Loughead J, Lerman C. Transcranial Direct Current Brain Stimulation Increases Ability to Resist Smoking. Brain Stimulation. PMID 26572280 DOI: 10.1016/J.Brs.2015.10.004  0.78
2015 Dubroff JG, Doot RK, Falcone M, Schnoll RA, Ray R, Tyndale RF, Brody AL, Hou C, Schmitz A, Lerman C. Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1724-9. PMID 26272810 DOI: 10.2967/Jnumed.115.155002  0.801
2015 Bergen AW, Michel M, Nishita D, Krasnow R, Javitz HS, Conneely KN, Lessov-Schlaggar CN, Hops H, Zhu AZ, Baurley JW, McClure JB, Hall SM, Baker TB, Conti DV, Benowitz NL, ... Lerman C, et al. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption. Plos One. 10: e0126113. PMID 26132489 DOI: 10.1371/Journal.Pone.0126113  0.456
2015 Chenoweth MJ, Schnoll RA, Novalen M, Hawk LW, George TP, Cinciripini PM, Lerman C, Tyndale RF. The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 26069034 DOI: 10.1093/Ntr/Ntv125  0.526
2015 Tanner JA, Novalen M, Jatlow P, Huestis MA, Murphy SE, Kaprio J, Kankaanpää A, Galanti L, Stefan C, George TP, Benowitz NL, Lerman C, Tyndale RF. Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26014804 DOI: 10.1158/1055-9965.Epi-14-1381  0.489
2015 Tyndale RF, Zhu AZ, George TP, Cinciripini P, Hawk LW, Schnoll RA, Swan GE, Benowitz NL, Heitjan DF, Lerman C. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking. Plos One. 10: e0128109. PMID 26010901 DOI: 10.1371/Journal.Pone.0128109  0.497
2015 Perkins KA, Karelitz JL, Michael VC, Fromuth M, Conklin CA, Chengappa KN, Hope C, Lerman C. Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 25895948 DOI: 10.1093/Ntr/Ntv085  0.451
2015 Hamilton DA, Mahoney MC, Novalen M, Chenoweth MJ, Heitjan DF, Lerman C, Tyndale RF, Hawk LW. Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 25732567 DOI: 10.1093/Ntr/Ntv031  0.467
2015 Lerman C, Schnoll RA, Hawk LW, Cinciripini P, George TP, Wileyto EP, Swan GE, Benowitz NL, Heitjan DF, Tyndale RF. Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. The Lancet. Respiratory Medicine. 3: 131-8. PMID 25588294 DOI: 10.1016/S2213-2600(14)70294-2  0.527
2015 Loughead J, Wileyto EP, Ruparel K, Falcone M, Hopson R, Gur R, Lerman C. Working memory-related neural activity predicts future smoking relapse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1311-20. PMID 25469682 DOI: 10.1038/Npp.2014.318  0.789
2014 Chenoweth MJ, Novalen M, Hawk LW, Schnoll RA, George TP, Cinciripini PM, Lerman C, Tyndale RF. Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1773-82. PMID 25012994 DOI: 10.1158/1055-9965.Epi-14-0427  0.494
2014 Leventhal AM, Lee W, Bergen AW, Swan GE, Tyndale RF, Lerman C, Conti DV. Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome. Drug and Alcohol Dependence. 138: 109-17. PMID 24667010 DOI: 10.1016/J.Drugalcdep.2014.02.016  0.522
2014 Lerman C, Gu H, Loughead J, Ruparel K, Yang Y, Stein EA. Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function. Jama Psychiatry. 71: 523-30. PMID 24622915 DOI: 10.1001/Jamapsychiatry.2013.4091  0.431
2014 Perkins KA, Lerman C. An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation. Psychopharmacology. 231: 1-11. PMID 24297304 DOI: 10.1007/S00213-013-3364-6  0.391
2014 Turner JR, Ray R, Lee B, Everett L, Xiang J, Jepson C, Kaestner KH, Lerman C, Blendy JA. Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence. Molecular Psychiatry. 19: 801-10. PMID 23999525 DOI: 10.1038/Mp.2013.104  0.765
2014 Ashare RL, Falcone M, Lerman C. Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology. 76: 581-91. PMID 23639437 DOI: 10.1016/J.Neuropharm.2013.04.034  0.762
2014 Falcone M, Wileyto EP, Ruparel K, Gerraty RT, LaPrate L, Detre JA, Gur R, Loughead J, Lerman C. Age-related differences in working memory deficits during nicotine withdrawal. Addiction Biology. 19: 907-17. PMID 23496760 DOI: 10.1111/Adb.12051  0.787
2013 Parvanta S, Gibson L, Forquer H, Shapiro-Luft D, Dean L, Freres D, Lerman C, Mallya G, Moldovan-Johnson M, Tan A, Cappella J, Hornik R. Applying Quantitative Approaches to the Formative Evaluation of Antismoking Campaign Messages. Social Marketing Quarterly. 19: 242-264. PMID 24817829 DOI: 10.1177/1524500413506004  0.309
2013 Ashare RL, Wileyto EP, Ruparel K, Goelz PM, Hopson RD, Valdez JN, Gur RC, Loughead J, Lerman C. Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study. Drug and Alcohol Dependence. 133: 852-6. PMID 24095246 DOI: 10.1016/J.Drugalcdep.2013.09.003  0.416
2013 David SP, Strong DR, Leventhal AM, Lancaster MA, McGeary JE, Munafò MR, Bergen AW, Swan GE, Benowitz NL, Tyndale RF, Conti DV, Brown RA, Lerman C, Niaura R. Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction (Abingdon, England). 108: 2202-11. PMID 23941313 DOI: 10.1111/Add.12325  0.48
2013 Ashare RL, Valdez JN, Ruparel K, Albelda B, Hopson RD, Keefe JR, Loughead J, Lerman C. Association of abstinence-induced alterations in working memory function and COMT genotype in smokers. Psychopharmacology. 230: 653-62. PMID 23828159 DOI: 10.1007/S00213-013-3197-3  0.376
2013 Falcone M, Smith RM, Chenoweth MJ, Bhattacharjee AK, Kelsoe JR, Tyndale RF, Lerman C. Neuroimaging in psychiatric pharmacogenetics research: the promise and pitfalls. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2327-37. PMID 23793356 DOI: 10.1038/Npp.2013.152  0.717
2013 Perkins KA, Lerman C, Karelitz JL, Jao NC, Chengappa KN, Sparks GM. Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications. Addiction (Abingdon, England). 108: 1962-8. PMID 23773319 DOI: 10.1111/Add.12273  0.428
2013 Falcone M, Lerman C, Cappella JN, Sanborn P, Jepson C, Strasser AA. No untoward effects of smoking cues in anti-smoking public service announcements. Drug and Alcohol Dependence. 133: 279-82. PMID 23742844 DOI: 10.1016/J.Drugalcdep.2013.05.006  0.786
2013 Perkins KA, Karelitz JL, Jao NC, Gur RC, Lerman C. Effects of bupropion on cognitive performance during initial tobacco abstinence. Drug and Alcohol Dependence. 133: 283-6. PMID 23726977 DOI: 10.1016/J.Drugalcdep.2013.05.003  0.454
2013 Wang AL, Ruparel K, Loughead JW, Strasser AA, Blady SJ, Lynch KG, Romer D, Cappella JN, Lerman C, Langleben DD. Content matters: neuroimaging investigation of brain and behavioral impact of televised anti-tobacco public service announcements. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 7420-7. PMID 23616548 DOI: 10.1523/Jneurosci.3840-12.2013  0.417
2013 Bough KJ, Lerman C, Rose JE, McClernon FJ, Kenny PJ, Tyndale RF, David SP, Stein EA, Uhl GR, Conti DV, Green C, Amur S. Biomarkers for smoking cessation. Clinical Pharmacology and Therapeutics. 93: 526-38. PMID 23588313 DOI: 10.1038/Clpt.2013.57  0.403
2013 Zhu AZ, Renner CC, Hatsukami DK, Swan GE, Lerman C, Benowitz NL, Tyndale RF. The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 708-18. PMID 23371292 DOI: 10.1158/1055-9965.Epi-12-1234-T  0.429
2013 Bergen AW, Javitz HS, Krasnow R, Nishita D, Michel M, Conti DV, Liu J, Lee W, Edlund CK, Hall S, Kwok PY, Benowitz NL, Baker TB, Tyndale RF, Lerman C, et al. Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Pharmacogenetics and Genomics. 23: 94-103. PMID 23249876 DOI: 10.1097/Fpc.0B013E32835Cdabd  0.501
2013 Bergen AW, Javitz HS, Su L, He Y, Conti DV, Benowitz NL, Tyndale RF, Lerman C, Swan GE. The DRD4 exon III VNTR, bupropion, and associations with prospective abstinence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 15: 1190-200. PMID 23212438 DOI: 10.1093/Ntr/Nts245  0.365
2013 Lee S, Cappella JN, Lerman C, Strasser AA. Effects of smoking cues and argument strength of antismoking advertisements on former smokers' self-efficacy, attitude, and intention to refrain from smoking. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 15: 527-33. PMID 22949578 DOI: 10.1093/Ntr/Nts171  0.487
2013 Loughead J, Ray R, Wileyto EP, Ruparel K, O'Donnell GP, Senecal N, Siegel S, Gur RC, Lerman C. Brain activity and emotional processing in smokers treated with varenicline. Addiction Biology. 18: 732-8. PMID 21507156 DOI: 10.1111/J.1369-1600.2011.00324.X  0.693
2012 Ashare RL, Karlawish JH, Wileyto EP, Pinto A, Lerman C. APOE ɛ4, an Alzheimer's disease susceptibility allele, and smoking cessation. The Pharmacogenomics Journal. 13: 538-43. PMID 23247396 DOI: 10.1038/Tpj.2012.49  0.481
2012 Featherstone RE, Phillips JM, Thieu T, Ehrlichman RS, Halene TB, Leiser SC, Christian E, Johnson E, Lerman C, Siegel SJ. Nicotine receptor subtype-specific effects on auditory evoked oscillations and potentials. Plos One. 7: e39775. PMID 22911690 DOI: 10.1371/Journal.Pone.0039775  0.403
2012 Kim HS, Bigman CA, Leader AE, Lerman C, Cappella JN. Narrative Health Communication and Behavior Change: The Influence of Exemplars in the News on Intention to Quit Smoking. The Journal of Communication. 62: 473-492. PMID 22736808 DOI: 10.1111/J.1460-2466.2012.01644.X  0.464
2012 Ashare RL, Ray R, Lerman C, Strasser AA. Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study. Drug and Alcohol Dependence. 126: 263-7. PMID 22595038 DOI: 10.1016/J.Drugalcdep.2012.04.019  0.732
2012 Lee W, Ray R, Bergen AW, Swan GE, Thomas P, Tyndale RF, Benowitz NL, Lerman C, Conti DV. DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers. Pharmacogenetics and Genomics. 22: 551-4. PMID 22495174 DOI: 10.1097/Fpc.0B013E3283539062  0.765
2012 Perkins KA, Giedgowd GE, Karelitz JL, Conklin CA, Lerman C. Smoking in response to negative mood in men versus women as a function of distress tolerance. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 14: 1418-25. PMID 22416115 DOI: 10.1093/Ntr/Nts075  0.44
2012 Falcone M, Gold AB, Wileyto EP, Ray R, Ruparel K, Newberg A, Dubroff J, Logan J, Zubieta JK, Blendy JA, Lerman C. μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief. Psychopharmacology. 222: 701-8. PMID 22389047 DOI: 10.1007/S00213-012-2673-5  0.831
2012 Gold AB, Wileyto EP, Lori A, Conti D, Cubells JF, Lerman C. Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1683-8. PMID 22373943 DOI: 10.1038/Npp.2012.13  0.514
2012 Javitz HS, Lerman C, Swan GE. Comparative dynamics of four smoking withdrawal symptom scales Addiction. 107: 1501-1511. PMID 22321019 DOI: 10.1111/J.1360-0443.2012.03838.X  0.467
2012 Cao YA, Featherstone RE, Gandal MJ, Liang Y, Jutzeler C, Saunders J, Tatard-Leitman V, Chen J, Weinberger DR, Lerman C, Siegel SJ. Nicotine normalizes event related potentials in COMT-Val-tg mice and increases gamma and theta spectral density. Behavioral Neuroscience. 126: 332-43. PMID 22309446 DOI: 10.1037/A0027047  0.393
2012 Gold AB, Lerman C. Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. Human Genetics. PMID 22290489 DOI: 10.1007/S00439-012-1143-9  0.547
2012 Schnoll RA, Wileyto EP, Lerman C. Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation. Addictive Behaviors. 37: 565-8. PMID 22244706 DOI: 10.1016/J.Addbeh.2011.12.009  0.521
2012 King DP, Paciga S, Pickering E, Benowitz NL, Bierut LJ, Conti DV, Kaprio J, Lerman C, Park PW. Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 641-50. PMID 22048466 DOI: 10.1038/Npp.2011.232  0.526
2012 Lee W, Bergen AW, Swan GE, Li D, Liu J, Thomas P, Tyndale RF, Benowitz NL, Lerman C, Conti DV. Gender-stratified gene and gene-treatment interactions in smoking cessation. The Pharmacogenomics Journal. 12: 521-32. PMID 21808284 DOI: 10.1038/Tpj.2011.30  0.448
2011 Falcone M, Jepson C, Sanborn P, Cappella JN, Lerman C, Strasser AA. Association of BDNF and COMT genotypes with cognitive processing of anti-smoking PSAs Genes, Brain and Behavior. 10: 862-867. PMID 21883922 DOI: 10.1111/J.1601-183X.2011.00726.X  0.773
2011 Schnoll RA, Cappella J, Lerman C, Pinto A, Patterson F, Wileyto EP, Bigman C, Leone F. A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial. Health Communication. 26: 735-42. PMID 21667366 DOI: 10.1080/10410236.2011.566829  0.489
2011 Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead JW, Divgi C, Blendy JA, Logan J, Zubieta JK, Lerman C. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proceedings of the National Academy of Sciences of the United States of America. 108: 9268-73. PMID 21576462 DOI: 10.1073/Pnas.1018699108  0.737
2011 Javitz HS, Swan GE, Lerman C. The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy. Addiction (Abingdon, England). 106: 1835-45. PMID 21561501 DOI: 10.1111/J.1360-0443.2011.03495.X  0.479
2011 Falcone M, Jepson C, Benowitz N, Bergen AW, Pinto A, Wileyto EP, Baldwin D, Tyndale RF, Lerman C, Ray R. Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 13: 498-503. PMID 21385908 DOI: 10.1093/Ntr/Ntr012  0.804
2011 Lee S, Cappella JN, Lerman C, Strasser AA. Smoking cues, argument strength, and perceived effectiveness of antismoking PSAs. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 13: 282-90. PMID 21330273 DOI: 10.1093/Ntr/Ntq255  0.466
2011 Strasser AA, Benowitz NL, Pinto AG, Tang KZ, Hecht SS, Carmella SG, Tyndale RF, Lerman CE. Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 234-8. PMID 21212060 DOI: 10.1158/1055-9965.Epi-10-0674  0.43
2010 Lerman C. Preclinical data elucidate molecular and neural mechanisms of perinatal nicotine effects on neurodevelopment and behavior: translational opportunities and implications. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2322-3. PMID 20948511 DOI: 10.1038/Npp.2010.147  0.353
2010 Perkins KA, Lerman C, Fonte CA, Mercincavage M, Stitzer ML, Chengappa KN, Jain A. Cross-validation of a new procedure for early screening of smoking cessation medications in humans. Clinical Pharmacology and Therapeutics. 88: 109-14. PMID 20485335 DOI: 10.1038/Clpt.2010.65  0.484
2010 Furberg H, Ostroff J, Lerman C, Sullivan PF. The public health utility of genome-wide association study results for smoking behavior. Genome Medicine. 2: 26. PMID 20423533 DOI: 10.1186/Gm147  0.479
2010 Rudnick ND, Strasser AA, Phillips JM, Jepson C, Patterson F, Frey JM, Turetsky BI, Lerman C, Siegel SJ. Mouse model predicts effects of smoking and varenicline on event-related potentials in humans. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 12: 589-97. PMID 20395358 DOI: 10.1093/Ntr/Ntq049  0.505
2010 Wei J, Ma JZ, Payne TJ, Cui W, Ray R, Mitra N, Lerman C, Li MD. Replication and extension of association of choline acetyltransferase with nicotine dependence in European and African American smokers. Human Genetics. 127: 691-8. PMID 20383528 DOI: 10.1007/S00439-010-0818-3  0.692
2010 Lerman C, Audrain-McGovern J. Reinforcing effects of smoking: more than a feeling. Biological Psychiatry. 67: 699-701. PMID 20362220 DOI: 10.1016/J.Biopsych.2010.02.014  0.443
2010 Lerman C, Jepson C, Wileyto EP, Patterson F, Schnoll R, Mroziewicz M, Benowitz N, Tyndale RF. Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy. Clinical Pharmacology and Therapeutics. 87: 553-7. PMID 20336063 DOI: 10.1038/Clpt.2010.3  0.399
2010 Perkins KA, Mercincavage M, Fonte CA, Lerman C. Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence Psychopharmacology. 210: 45-51. PMID 20306175 DOI: 10.1007/S00213-010-1816-9  0.475
2010 Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S, Gur RC, Lerman C. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biological Psychiatry. 67: 715-21. PMID 20207347 DOI: 10.1016/J.Biopsych.2010.01.016  0.734
2010 Leader AE, Lerman C, Cappella JN. Nicotine vaccines: will smokers take a shot at quitting? Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 12: 390-7. PMID 20185516 DOI: 10.1093/Ntr/Ntq015  0.403
2010 Ray R, Mitra N, Baldwin D, Guo M, Patterson F, Heitjan DF, Jepson C, Wileyto EP, Wei J, Payne T, Ma JZ, Li MD, Lerman C. Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1374-82. PMID 20147892 DOI: 10.1038/Npp.2010.7  0.78
2010 Schnoll RA, Patterson F, Wileyto EP, Heitjan DF, Shields AE, Asch DA, Lerman C. Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Annals of Internal Medicine. 152: 144-51. PMID 20124230 DOI: 10.7326/0003-4819-152-3-201002020-00005  0.403
2010 Morgan G, Backinger C, Lerman C, Vocci F. Translational medication development for nicotine addiction. American Journal of Health Behavior. 34: 267-74. PMID 20001184 DOI: 10.5993/Ajhb.34.3.2  0.354
2010 Patterson F, Jepson C, Loughead J, Perkins K, Strasser AA, Siegel S, Frey J, Gur R, Lerman C. Working memory deficits predict short-term smoking resumption following brief abstinence Drug and Alcohol Dependence. 106: 61-64. PMID 19733449 DOI: 10.1016/J.Drugalcdep.2009.07.020  0.421
2010 Schnoll RA, Lerman C. Abstract PL01-06: Nicotine-dependence pharmacogenetics: Implications for personalized therapy Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-Pl01-06  0.513
2009 Perkins KA, Lerman C, Mercincavage M, Fonte CA, Briski JL. Nicotinic acetylcholine receptor β2 subunit (CHRNB2) gene and short-term ability to quit smoking in response to nicotine patch Cancer Epidemiology Biomarkers and Prevention. 18: 2608-2612. PMID 19755656 DOI: 10.1158/1055-9965.Epi-09-0166  0.516
2009 Ray R, Schnoll RA, Lerman C. Nicotine dependence: biology, behavior, and treatment. Annual Review of Medicine. 60: 247-60. PMID 19630572 DOI: 10.1146/Annurev.Med.60.041707.160511  0.751
2009 Thomas PD, Mi H, Swan GE, Lerman C, Benowitz N, Tyndale RF, Bergen AW, Conti DV. A systems biology network model for genetic association studies of nicotine addiction and treatment. Pharmacogenetics and Genomics. 19: 538-51. PMID 19525886 DOI: 10.1097/Fpc.0B013E32832E2Ced  0.431
2009 Bergen AW, Conti DV, Van Den Berg D, Lee W, Liu J, Li D, Guo N, Mi H, Thomas PD, Lessov-Schlaggar CN, Krasnow R, He Y, Nishita D, Jiang R, McClure JB, ... ... Lerman C, et al. Dopamine genes and nicotine dependence in treatment-seeking and community smokers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2252-64. PMID 19494806 DOI: 10.1038/Npp.2009.52  0.462
2009 Kang Y, Cappella JN, Strasser AA, Lerman C. The effect of smoking cues in antismoking advertisements on smoking urge and psychophysiological reactions. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 254-61. PMID 19251767 DOI: 10.1093/Ntr/Ntn033  0.476
2009 Strasser AA, Cappella JN, Jepson C, Fishbein M, Tang KZ, Han E, Lerman C. Experimental evaluation of antitobacco PSAs: effects of message content and format on physiological and behavioral outcomes. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 293-302. PMID 19246628 DOI: 10.1093/Ntr/Ntn026  0.345
2009 Stepanov I, Carmella SG, Han S, Pinto A, Strasser AA, Lerman C, Hecht SS. Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 99-105. PMID 19246447 DOI: 10.1093/Ntr/Ntn004  0.377
2009 Perkins KA, Briski J, Fonte C, Scott J, Lerman C. Severity of tobacco abstinence symptoms varies by time of day. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 84-91. PMID 19246445 DOI: 10.1093/Ntr/Ntn003  0.31
2009 Newberg AB, Ray R, Scheuermann J, Wintering N, Saffer J, Schmitz A, Freifelder R, Karp J, Lerman C, Divgi C. Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent. Nuclear Medicine Communications. 30: 314-8. PMID 19242386 DOI: 10.1097/Mnm.0B013E328329A0Ec  0.638
2009 Ray R, Tyndale RF, Lerman C. Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. Journal of Neurogenetics. 23: 252-61. PMID 19169923 DOI: 10.1080/01677060802572887  0.77
2009 Loughead J, Wileyto EP, Valdez JN, Sanborn P, Tang K, Strasser AA, Ruparel K, Ray R, Gur RC, Lerman C. Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype. Molecular Psychiatry. 14: 820-6. PMID 19065145 DOI: 10.1038/Mp.2008.132  0.755
2009 Schnoll RA, Patterson F, Wileyto EP, Tyndale RF, Benowitz N, Lerman C. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacology, Biochemistry, and Behavior. 92: 6-11. PMID 19000709 DOI: 10.1016/J.Pbb.2008.10.016  0.514
2009 Patterson F, Jepson C, Strasser AA, Loughead J, Perkins KA, Gur RC, Frey JM, Siegel S, Lerman C. Varenicline improves mood and cognition during smoking abstinence. Biological Psychiatry. 65: 144-9. PMID 18842256 DOI: 10.1016/J.Biopsych.2008.08.028  0.459
2009 Perkins KA, Coddington SB, Karelitz JL, Jetton C, Scott JA, Wilson AS, Lerman C. Variability in initial nicotine sensitivity due to sex, history of other drug use, and parental smoking. Drug and Alcohol Dependence. 99: 47-57. PMID 18775605 DOI: 10.1016/J.Drugalcdep.2008.06.017  0.504
2008 Penning TM, Lerman C. Genomics of smoking exposure and cessation: lessons for cancer prevention and treatment. Cancer Prevention Research (Philadelphia, Pa.). 1: 80-3. PMID 19138939 DOI: 10.1158/1940-6207.Capr-08-0047  0.493
2008 Furberg H, Lichtenstein P, Pedersen NL, Thornton L, Bulik CM, Lerman C, Sullivan PF. The STAGE cohort: A prospective study of tobacco use among Swedish twins Nicotine and Tobacco Research. 10: 1727-1735. PMID 18988069 DOI: 10.1080/14622200802443551  0.424
2008 Raybuck JD, Portugal GS, Lerman C, Gould TJ. Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice. Behavioral Neuroscience. 122: 1166-71. PMID 18823172 DOI: 10.1037/A0012601  0.468
2008 Perkins KA, Lerman C, Grottenthaler A, Ciccocioppo MM, Milanak M, Conklin CA, Bergen AW, Benowitz NL. Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. Behavioural Pharmacology. 19: 641-9. PMID 18690118 DOI: 10.1097/Fbp.0B013E32830C367C  0.526
2008 Perkins KA, Lerman C, Coddington S, Jetton C, Karelitz JL, Wilson A, Jennings JR, Ferrell R, Bergen AW, Benowitz NL. Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers. Behavioural Pharmacology. 19: 630-40. PMID 18690117 DOI: 10.1097/Fbp.0B013E32830C3621  0.428
2008 Perkins KA, Lerman C, Coddington S, Karelitz JL. Association of retrospective early smoking experiences with prospective sensitivity to nicotine via nasal spray in nonsmokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 10: 1335-45. PMID 18686181 DOI: 10.1080/14622200802238886  0.509
2008 Furberg H, Lichtenstein P, Pedersen NL, Bulik CM, Lerman C, Sullivan PF. Snus use and other correlates of smoking cessation in the Swedish Twin Registry Psychological Medicine. 38: 1299-1308. PMID 18680625 DOI: 10.1017/S0033291707002346  0.464
2008 Perkins KA, Lerman C, Coddington SB, Jetton C, Karelitz JL, Scott JA, Wilson AS. Initial nicotine sensitivity in humans as a function of impulsivity. Psychopharmacology. 200: 529-44. PMID 18604520 DOI: 10.1007/S00213-008-1231-7  0.482
2008 Ray R, Loughead J, Wang Z, Detre J, Yang E, Gur R, Lerman C. Neuroimaging, genetics and the treatment of nicotine addiction Behavioural Brain Research. 193: 159-169. PMID 18599130 DOI: 10.1016/J.Bbr.2008.05.021  0.737
2008 Conti DV, Lee W, Li D, Liu J, Van Den Berg D, Thomas PD, Bergen AW, Swan GE, Tyndale RF, Benowitz NL, Lerman C. Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Human Molecular Genetics. 17: 2834-48. PMID 18593715 DOI: 10.1093/Hmg/Ddn181  0.46
2008 Shields AE, Levy DE, Blumenthal D, Currivan D, McGinn-Shapiro M, Weiss KB, Yucel R, Lerman C. Primary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 10: 1037-45. PMID 18584467 DOI: 10.1080/14622200802087580  0.435
2008 Piper ME, McCarthy DE, Bolt DM, Smith SS, Lerman C, Benowitz N, Fiore MC, Baker TB. Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 10: 1009-20. PMID 18584464 DOI: 10.1080/14622200802097563  0.536
2008 David SP, Johnstone EC, Murphy MF, Aveyard P, Guo B, Lerman C, Munafò MR. Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. Drug and Alcohol Dependence. 98: 77-85. PMID 18562131 DOI: 10.1016/J.Drugalcdep.2008.04.013  0.414
2008 Schnoll RA, Wileyto EP, Pinto A, Leone F, Gariti P, Siegel S, Perkins KA, Dackis C, Heitjan DF, Berrettini W, Lerman C. A placebo-controlled trial of modafinil for nicotine dependence. Drug and Alcohol Dependence. 98: 86-93. PMID 18541389 DOI: 10.1016/J.Drugalcdep.2008.04.008  0.517
2008 Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE, David SP, Niaura R, Lerman C. Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Archives of General Psychiatry. 65: 683-93. PMID 18519826 DOI: 10.1001/Archpsyc.65.6.683  0.492
2008 Ray R, Rukstalis M, Jepson C, Strasser A, Patterson F, Lynch K, Lerman C. Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence. Journal of Psychopharmacology (Oxford, England). 23: 168-76. PMID 18515446 DOI: 10.1177/0269881108089580  0.76
2008 Wang Z, Ray R, Faith M, Tang K, Wileyto EP, Detre JA, Lerman C. Nicotine abstinence-induced cerebral blood flow changes by genotype. Neuroscience Letters. 438: 275-80. PMID 18499348 DOI: 10.1016/J.Neulet.2008.04.084  0.75
2008 Perkins KA, Lerman C, Stitzer M, Fonte CA, Briski JL, Scott JA, Chengappa KN. Development of procedures for early screening of smoking cessation medications in humans. Clinical Pharmacology and Therapeutics. 84: 216-21. PMID 18388880 DOI: 10.1038/Clpt.2008.30  0.519
2008 Patterson F, Schnoll RA, Wileyto EP, Pinto A, Epstein LH, Shields PG, Hawk LW, Tyndale RF, Benowitz N, Lerman C. Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion. Clinical Pharmacology and Therapeutics. 84: 320-5. PMID 18388868 DOI: 10.1038/Clpt.2008.57  0.491
2008 Heitjan DF, Asch DA, Ray R, Rukstalis M, Patterson F, Lerman C. Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment Pharmacogenomics Journal. 8: 391-399. PMID 18347612 DOI: 10.1038/Sj.Tpj.6500492  0.737
2008 Patterson F, Kerrin K, Wileyto EP, Lerman C. Increase in anger symptoms after smoking cessation predicts relapse. Drug and Alcohol Dependence. 95: 173-6. PMID 18328642 DOI: 10.1016/J.Drugalcdep.2008.01.013  0.485
2008 Shields A, Lerman C. Anticipating Clinical Integration of Pharmacogenetic Treatment Strategies for Addiction: Are Primary Care Physicians Ready? Clinical Pharmacology & Therapeutics. 83: 635-639. PMID 18323859 DOI: 10.1038/Clpt.2008.4  0.316
2008 Heitjan DF, Guo M, Ray R, Wileyto EP, Epstein LH, Lerman C. Identification of pharmacogenetic markers in smoking cessation therapy. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 712-9. PMID 18165968 DOI: 10.1002/Ajmg.B.30669  0.707
2008 Schnoll RA, Epstein L, Audrain J, Niaura R, Hawk L, Shields PG, Lerman C, Wileyto EP. Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation. Journal of Substance Abuse Treatment. 34: 234-41. PMID 17600649 DOI: 10.1016/J.Jsat.2007.04.004  0.433
2007 Wang Z, Faith M, Patterson F, Tang K, Kerrin K, Wileyto EP, Detre JA, Lerman C. Neural substrates of abstinence-induced cigarette cravings in chronic smokers. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 14035-40. PMID 18094242 DOI: 10.1523/Jneurosci.2966-07.2007  0.476
2007 Phillips JM, Siegel SJ, Shields AE, Patterson F, Gould TJ, Strasser AA, Ray R, Pinto A, Audrain-McGovern J, Rukstalis M, Perkins KA, Blendy JA, Lerman C. Translating basic science to improve pharmacotherapy for nicotine dependence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: S583-98. PMID 18067034 DOI: 10.1080/14622200701691755  0.713
2007 David SP, Strong DR, Munafò MR, Brown RA, Lloyd-Richardson EE, Wileyto PE, Evins EA, Shields PG, Lerman C, Niaura R. Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 1251-7. PMID 18058343 DOI: 10.1080/14622200701705027  0.395
2007 Lerman CE, Schnoll RA, Munafò MR. Genetics and smoking cessation improving outcomes in smokers at risk. American Journal of Preventive Medicine. 33: S398-405. PMID 18021915 DOI: 10.1016/j.amepre.2007.09.006  0.453
2007 Ray R, Jepson C, Wileyto EP, Dahl JP, Patterson F, Rukstalis M, Pinto A, Berrettini W, Lerman C. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 1237-41. PMID 17978999 DOI: 10.1080/14622200701648367  0.737
2007 Schnoll RA, Patterson F, Lerman C. Treating tobacco dependence in women. Journal of Women's Health (2002). 16: 1211-8. PMID 17937574 DOI: 10.1089/Jwh.2006.0281  0.416
2007 Schnoll RA, Johnson TA, Lerman C. Genetics and smoking behavior. Current Psychiatry Reports. 9: 349-57. PMID 17915073 DOI: 10.1007/S11920-007-0045-3  0.491
2007 Hutchison KE, Allen DL, Filbey FM, Jepson C, Lerman C, Benowitz NL, Stitzel J, Bryan A, McGeary J, Haughey HM. CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Archives of General Psychiatry. 64: 1078-86. PMID 17768273 DOI: 10.1001/Archpsyc.64.9.1078  0.503
2007 Lerman C, LeSage MG, Perkins KA, O'Malley SS, Siegel SJ, Benowitz NL, Corrigall WA. Translational research in medication development for nicotine dependence. Nature Reviews. Drug Discovery. 6: 746-62. PMID 17690709 DOI: 10.1038/Nrd2361  0.343
2007 David SP, Brown RA, Papandonatos GD, Kahler CW, Lloyd-Richardson EE, Munafò MR, Shields PG, Lerman C, Strong D, McCaffery J, Niaura R. Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 821-33. PMID 17654295 DOI: 10.1080/14622200701382033  0.429
2007 Leventhal AM, Waters AJ, Boyd S, Moolchan ET, Heishman SJ, Lerman C, Pickworth WB. Associations between Cloninger's temperament dimensions and acute tobacco withdrawal. Addictive Behaviors. 32: 2976-89. PMID 17624682 DOI: 10.1016/J.Addbeh.2007.06.014  0.519
2007 Waters AJ, Heishman SJ, Lerman C, Pickworth W. Enhanced identification of smoking-related words during the attentional blink in smokers. Addictive Behaviors. 32: 3077-82. PMID 17616446 DOI: 10.1016/J.Addbeh.2007.05.016  0.401
2007 Ray R, Jepson C, Wileyto P, Patterson F, Strasser AA, Rukstalis M, Perkins K, Blendy J, Lerman C. CREB1 haplotypes and the relative reinforcing value of nicotine. Molecular Psychiatry. 12: 615-7. PMID 17592483 DOI: 10.1038/Sj.Mp.4002002  0.709
2007 Ray R, Schnoll RA, Lerman C. Pharmacogenetics and smoking cessation with nicotine replacement therapy. Cns Drugs. 21: 525-33. PMID 17579497 DOI: 10.2165/00023210-200721070-00001  0.77
2007 Lee AM, Jepson C, Shields PG, Benowitz N, Lerman C, Tyndale RF. CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1312-4. PMID 17548706 DOI: 10.1158/1055-9965.Epi-07-0188  0.392
2007 Newberg A, Lerman C, Wintering N, Ploessl K, Mozley PD. Dopamine transporter binding in smokers and nonsmokers. Clinical Nuclear Medicine. 32: 452-455. PMID 17515751 DOI: 10.1097/01.Rlu.0000262980.98342.Dd  0.4
2007 Strasser AA, Malaiyandi V, Hoffmann E, Tyndale RF, Lerman C. An association of CYP2A6 genotype and smoking topography. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 511-8. PMID 17454707 DOI: 10.1080/14622200701239605  0.51
2007 Leventhal AM, Waters AJ, Boyd S, Moolchan ET, Lerman C, Pickworth WB. Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Experimental and Clinical Psychopharmacology. 15: 21-36. PMID 17295582 DOI: 10.1037/1064-1297.15.1.21  0.487
2007 Lee AM, Jepson C, Hoffmann E, Epstein L, Hawk LW, Lerman C, Tyndale RF. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial. Biological Psychiatry. 62: 635-41. PMID 17223085 DOI: 10.1016/J.Biopsych.2006.10.005  0.451
2007 Strasser AA, Lerman C, Sanborn PM, Pickworth WB, Feldman EA. New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure Drug and Alcohol Dependence. 86: 294-300. PMID 16930853 DOI: 10.1016/J.Drugalcdep.2006.06.017  0.53
2007 Berrettini WH, Wileyto EP, Epstein L, Restine S, Hawk L, Shields P, Niaura R, Lerman C. Catechol-O-Methyltransferase (COMT) Gene Variants Predict Response to Bupropion Therapy for Tobacco Dependence Biological Psychiatry. 61: 111-118. PMID 16876132 DOI: 10.1016/J.Biopsych.2006.04.030  0.466
2007 David SP, Brown RA, Papandonatos GD, Kahler CW, Lloyd-Richardson EE, Munafò MR, Shields PG, Lerman C, Strong D, McCaffery J, Niura R. Erratum: Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation (Nicotine and Tobacco Research (2007) vol. 9 (8) (821-833)) Nicotine & Tobacco Research. 9. DOI: 10.1080/14622200701773611  0.496
2006 Strasser AA, Lerman C, Cappella JN. Lower nicotine cigarettes may not lower harm. Ldi Issue Brief. 12: 1-4. PMID 17302017  0.421
2006 Munafò M, Lerman C. Can pharmacogenetics help smokers quit Pharmacogenomics. 7: 1137-1140. PMID 17184199 DOI: 10.2217/14622416.7.8.1137  0.536
2006 Hu J, Redden DT, Berrettini WH, Shields PG, Restine SL, Pinto A, Lerman C, Allison DB. No evidence for a major role of polymorphisms during bupropion treatment. Obesity (Silver Spring, Md.). 14: 1863-7. PMID 17135598 DOI: 10.1038/Oby.2006.215  0.4
2006 Ray R, Jepson C, Patterson F, Strasser A, Rukstalis M, Perkins K, Lynch KG, O'Malley S, Berrettini WH, Lerman C. Association of OPRM1 A118G variant with the relative reinforcing value of nicotine. Psychopharmacology. 188: 355-63. PMID 16960700 DOI: 10.1007/S00213-006-0504-2  0.713
2006 Schnoll RA, Lerman C. Current and emerging pharmacotherapies for treating tobacco dependence. Expert Opinion On Emerging Drugs. 11: 429-444. PMID 16939383 DOI: 10.1517/14728214.11.3.429  0.517
2006 Lerman C. Helping smokers quit through pharmacogenetics. Ldi Issue Brief. 11: 1-4. PMID 16827222  0.423
2006 Lerman C, Tyndale R, Patterson F, Wileyto EP, Shields PG, Pinto A, Benowitz N. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clinical Pharmacology and Therapeutics. 79: 600-8. PMID 16765148 DOI: 10.1016/J.Clpt.2006.02.006  0.505
2006 Shadel WG, Lerman C, Cappella J, Strasser AA, Pinto A, Hornik R. Evaluating smokers' reactions to advertising for new lower nicotine quest cigarettes. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 20: 80-4. PMID 16536669 DOI: 10.1037/0893-164X.20.1.80  0.506
2006 Munafò MR, Johnstone EC, Wileyto EP, Shields PG, Elliot KM, Lerman C. Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 398-400. PMID 16492936 DOI: 10.1158/1055-9965.Epi-05-0648  0.475
2006 Volpp KG, Gurmankin Levy A, Asch DA, Berlin JA, Murphy JJ, Gomez A, Sox H, Zhu J, Lerman C. A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 12-8. PMID 16434580 DOI: 10.1158/1055-9965.Epi-05-0314  0.372
2006 Malaiyandi V, Lerman C, Benowitz NL, Jepson C, Patterson F, Tyndale RF. Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Molecular Psychiatry. 11: 400-9. PMID 16402128 DOI: 10.1038/Sj.Mp.4001794  0.485
2006 Dahl JP, Jepson C, Levenson R, Wileyto EP, Patterson F, Berrettini WH, Lerman C. Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence. The Pharmacogenomics Journal. 6: 194-9. PMID 16402081 DOI: 10.1038/Sj.Tpj.6500358  0.394
2006 Furberg H, Bulik CM, Lerman C, Lichtenstein P, Pedersen NL, Sullivan PF. Is Swedish snus associated with smoking initiation or smoking cessation? Tobacco Control. 14: 422-4. PMID 16319367 DOI: 10.1136/Tc.2005.012476  0.532
2006 Perkins KA, Stitzer M, Lerman C. Medication screening for smoking cessation: a proposal for new methodologies. Psychopharmacology. 184: 628-36. PMID 16163529 DOI: 10.1007/S00213-005-0105-5  0.331
2006 Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F, Kaufmann V, Restine S, Hawk L, Niaura R, Berrettini W. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: Results of two randomized clinical trials Neuropsychopharmacology. 31: 231-242. PMID 16123753 DOI: 10.1038/Sj.Npp.1300861  0.451
2005 Schnoll RA, Rothman RL, Wielt DB, Lerman C, Pedri H, Wang H, Babb J, Miller SM, Movsas B, Sherman E, Ridge JA, Unger M, Langer C, Goldberg M, Scott W, et al. A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 30: 1-11. PMID 16097900 DOI: 10.1207/S15324796Abm3001_1  0.486
2005 Furberg H, Sullivan PF, Maes H, Prescott CA, Lerman C, Bulik C, Kendler KS. The types of regular cigarette smokers: a latent class analysis. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 7: 351-60. PMID 16085503 DOI: 10.1080/14622200500124917  0.515
2005 Berrettini WH, Lerman CE. Pharmacotherapy and pharmacogenetics of nicotine dependence. The American Journal of Psychiatry. 162: 1441-51. PMID 16055765 DOI: 10.1176/APPI.AJP.162.8.1441  0.363
2005 Wileyto EP, Patterson F, Niaura R, Epstein LH, Brown RA, Audrain-McGovern J, Hawk LW, Lerman C. Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 7: 257-68. PMID 16036283 DOI: 10.1080/14622200500055673  0.379
2005 Munafò MR, Shields AE, Berrettini WH, Patterson F, Lerman C. Pharmacogenetics and nicotine addiction treatment. Pharmacogenomics. 6: 211-23. PMID 16013953 DOI: 10.1517/14622416.6.3.211  0.5
2005 Munafò MR, Lerman C, Niaura R, Shields AE, Swan GE. Smoking cessation treatment: pharmacogenetic assessment. Current Opinion in Molecular Therapeutics. 7: 202-8. PMID 15977416  0.315
2005 Redden DT, Shields PG, Epstein L, Wileyto EP, Zakharkin SO, Allison DB, Lerman C. Catechol-O-methyl-transferase functional polymorphism and nicotine dependence: an evaluation of nonreplicated results. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 1384-9. PMID 15941945 DOI: 10.1158/1055-9965.Epi-04-0649  0.44
2005 Rukstalis M, Jepson C, Patterson F, Lerman C. Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. Journal of Substance Abuse Treatment. 28: 297-304. PMID 15925263 DOI: 10.1016/J.Jsat.2005.02.002  0.412
2005 Siegel SJ, Maxwell CR, Majumdar S, Trief DF, Lerman C, Gur RE, Kanes SJ, Liang Y. Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials. Neuroscience. 133: 729-38. PMID 15908134 DOI: 10.1016/J.Neuroscience.2005.03.027  0.346
2005 Colilla S, Lerman C, Shields PG, Jepson C, Rukstalis M, Berlin J, DeMichele A, Bunin G, Strom BL, Rebbeck TR. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenetics and Genomics. 15: 393-8. PMID 15900212 DOI: 10.1097/01213011-200506000-00004  0.468
2005 Shields AE, Blumenthal D, Weiss KB, Comstock CB, Currivan D, Lerman C. Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians. Journal of General Internal Medicine. 20: 131-8. PMID 15836545 DOI: 10.1111/J.1525-1497.2005.30429.X  0.457
2005 Blendy JA, Strasser A, Walters CL, Perkins KA, Patterson F, Berkowitz R, Lerman C. Reduced nicotine reward in obesity: cross-comparison in human and mouse. Psychopharmacology. 180: 306-15. PMID 15719224 DOI: 10.1007/S00213-005-2167-9  0.393
2005 Rukstalis M, Jepson C, Strasser A, Lynch KG, Perkins K, Patterson F, Lerman C. Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm. Psychopharmacology. 180: 41-8. PMID 15682300 DOI: 10.1007/S00213-004-2136-8  0.51
2005 Shields AE, Fortun M, Hammonds EM, King PA, Lerman C, Rapp R, Sullivan PF. The use of race variables in genetic studies of complex traits and the goal of reducing health disparities: a transdisciplinary perspective. The American Psychologist. 60: 77-103. PMID 15641924 DOI: 10.1037/0003-066X.60.1.77  0.301
2005 Lerman C, Patterson F, Berrettini W. Treating tobacco dependence: state of the science and new directions. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 311-23. PMID 15637394 DOI: 10.1200/Jco.2005.04.058  0.493
2005 Strasser AA, Kaufmann V, Jepson C, Perkins KA, Pickworth WB, Wileyto EP, Rukstalis M, Audrain-McGovern J, Lerman C. Effects of different nicotine replacement therapies on postcessation psychological responses. Addictive Behaviors. 30: 9-17. PMID 15561445 DOI: 10.1016/J.Addbeh.2004.04.005  0.408
2005 Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH. Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers. Molecular Psychiatry. 10: 407-14. PMID 15381926 DOI: 10.1038/Sj.Mp.4001588  0.46
2005 Cappella JN, Lerman C, Romantan A, Baruh L. News about genetics and smoking: Priming, family smoking history, and news story believability on inferences of genetic susceptibility to tobacco addiction Communication Research. 32: 478-502. DOI: 10.1177/0093650205277320  0.49
2004 Lerman C, Niaura R, Collins BN, Wileyto P, Audrain-McGovern J, Pinto A, Hawk L, Epstein LH. Effect of bupropion on depression symptoms in a smoking cessation clinical trial Psychology of Addictive Behaviors. 18: 362-366. PMID 15631608 DOI: 10.1037/0893-164X.18.4.362  0.372
2004 Strasser AA, Pickworth WB, Patterson F, Lerman C. Smoking topography predicts abstinence following treatment with nicotine replacement therapy. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1800-4. PMID 15533910  0.42
2004 Shields AE, Lerman C, Sullivan PF. Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations. Nicotine & Tobacco Research. 6: 675-688. PMID 15370164 DOI: 10.1080/14622200410001734058  0.476
2004 Jaroni JL, Wright SM, Lerman C, Epstein LH. Relationship between education and delay discounting in smokers. Addictive Behaviors. 29: 1171-5. PMID 15236819 DOI: 10.1016/J.Addbeh.2004.03.014  0.356
2004 Audrain-McGovern J, Lerman C, Wileyto EP, Rodriguez D, Shields PG. Interacting effects of genetic predisposition and depression on adolescent smoking progression. The American Journal of Psychiatry. 161: 1224-30. PMID 15229055 DOI: 10.1176/Appi.Ajp.161.7.1224  0.449
2004 Wileyto EP, Patterson F, Niaura R, Epstein LH, Brown RA, Audrain-McGovern J, Hawk LW, Lerman C. Do small lapses predict relapse to smoking behavior under bupropion treatment? Nicotine and Tobacco Research. 6: 357-367. PMID 15203809 DOI: 10.1080/1462220042000202463  0.412
2004 Perkins KA, Lerman C, Keenan J, Fonte C, Coddington S. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 6: 501-7. PMID 15203784 DOI: 10.1080/14622200410001696547  0.49
2004 Lerman C, Berrettini W, Pinto A, Patterson F, Crystal-Mansour S, Wileyto EP, Restine SL, Leonard DGB, Shields PG, Epstein LH. Changes in food reward following smoking cessation: A pharmacogenetic investigation Psychopharmacology. 174: 571-577. PMID 15138759 DOI: 10.1007/S00213-004-1823-9  0.432
2004 Schnoll RA, Rothman RL, Newman H, Lerman C, Miller SM, Movsas B, Sherman E, Ridge JA, Unger M, Langer C, Goldberg M, Scott W, Cheng J. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients. Psycho-Oncology. 13: 346-58. PMID 15133775 DOI: 10.1002/Pon.756  0.503
2004 Patterson F, Lerman C, Kaufmann VG, Neuner GA, Audrain-McGovern J. Cigarette smoking practices among American college students: review and future directions. Journal of American College Health : J of Ach. 52: 203-10. PMID 15029942 DOI: 10.3200/Jach.52.5.203-212  0.456
2004 Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J, Benowitz N. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. Annals of Internal Medicine. 140: 426-33. PMID 15023708 DOI: 10.7326/0003-4819-140-6-200403160-00009  0.423
2004 Lerman C, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S, Shields PG, Kaufmann V, Redden D, Benowitz N, Berrettini WH. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial Pharmacogenomics Journal. 4: 184-192. PMID 15007373 DOI: 10.1038/Sj.Tpj.6500238  0.429
2004 Schnoll RA, Rothman RL, Lerman C, Miller SM, Newman H, Movsas B, Sherman E, Ridge JA, Unger M, Langer C, Goldberg M, Scott W, Cheng J. Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollment. Head & Neck. 26: 278-86. PMID 14999804 DOI: 10.1002/Hed.10368  0.44
2004 Collins BN, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Kaufmann V, Pinto A, Hawk L, Niaura R, Epstein LH, Lerman C. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling Nicotine and Tobacco Research. 6: 27-37. PMID 14982685 DOI: 10.1080/14622200310001656830  0.483
2004 Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH. Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms. The Pharmacogenomics Journal. 4: 102-9. PMID 14732864 DOI: 10.1038/Sj.Tpj.6500227  0.378
2003 Baker TB, Hatsukami DK, Lerman C, O'Malley SS, Shields AE, Fiore MC. Transdisciplinary science applied to the evaluation of treatments for tobacco use Nicotine and Tobacco Research. 5. PMID 14668089 DOI: 10.1080/14622200310001625564  0.313
2003 Shenassa ED, McCaffery JM, Swan GE, Khroyan TV, Shakib S, Lerman C, Lyons M, Mouttapa M, Niaura RS, Buka SL, Leslie F, Santangelo SL. Intergenerational transmission of tobacco use and dependence: a transdisciplinary perspective. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 5: S55-69. PMID 14668087 DOI: 10.1080/14622200310001625500  0.478
2003 Morgan GD, Kobus K, Gerlach KK, Neighbors C, Lerman C, Abrams DB, Rimer BK. Facilitating transdisciplinary research: the experience of the transdisciplinary tobacco use research centers. Nicotine & Tobacco Research. 5: 11-19. PMID 14668084 DOI: 10.1080/14622200310001625537  0.349
2003 Kaufmann V, Jepson C, Rukstalis M, Perkins K, Audrain-McGovern J, Lerman C. Subjective effects of an initial dose of nicotine nasal spray predict treatment outcome. Psychopharmacology. 172: 271-6. PMID 14647969 DOI: 10.1007/S00213-003-1659-8  0.484
2003 Patterson F, Jepson C, Kaufmann V, Rukstalis M, Audrain-McGovern J, Kucharski S, Lerman C. Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling. Drug and Alcohol Dependence. 72: 123-31. PMID 14636967 DOI: 10.1016/S0376-8716(03)00194-7  0.503
2003 Lerman C, Wileyto EP, Audrain J, Pinto A, Kucharski S, Niaura R, Shields PG, Hawk LH, Krishnan S, Epstein LH. Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial Health Psychology. 22: 541-548. PMID 14570538 DOI: 10.1037/0278-6133.22.5.541  0.482
2003 Audrain-McGovern J, Tercyak KP, Shields AE, Bush A, Espinel CF, Lerman C. Which Adolescents Are Most Receptive to Tobacco Industry Marketing? Implications for Counter-Advertising Campaigns Health Communication. 15: 499-513. PMID 14527869 DOI: 10.1207/S15327027Hc1504_07  0.429
2003 Kaufmann V, Lerman C. Genes, smoking, and treatment response American Journal of Health-System Pharmacy. 60: 1911-1911. PMID 14521049 DOI: 10.1093/Ajhp/60.18.1911  0.443
2003 Miksys S, Lerman C, Shields PG, Mash DC, Tyndale RF. Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology. 45: 122-32. PMID 12814665 DOI: 10.1016/S0028-3908(03)00136-9  0.407
2003 Epstein LH, Richards JB, Saad FG, Paluch RA, Roemmich JN, Lerman C. Comparison between two measures of delay discounting in smokers. Experimental and Clinical Psychopharmacology. 11: 131-8. PMID 12755457 DOI: 10.1037/1064-1297.11.2.131  0.302
2003 Patterson F, Benowitz N, Shields P, Kaufmann V, Jepson C, Wileyto P, Kucharski S, Lerman C. Individual differences in nicotine intake per cigarette. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 468-71. PMID 12750245  0.442
2003 Lerman C, Berrettini W. Elucidating the role of genetic factors in smoking behavior and nicotine dependence. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 48-54. PMID 12627466 DOI: 10.1002/Ajmg.B.10003  0.512
2003 Miksys S, Lerman C, Shields P, Mash D, Tyndale R. The influence of smoking, alcoholism and genetics on CYP2B6 in human brain Clinical Pharmacology & Therapeutics. 73: P59-P59. DOI: 10.1016/S0009-9236(03)90576-5  0.392
2002 Epstein LH, Jaroni JL, Paluch RA, Leddy JJ, Vahue HE, Hawk L, Wileyto EP, Shields PG, Lerman C. Dopamine transporter genotype as a risk factor for obesity in African-American smokers. Obesity Research. 10: 1232-40. PMID 12490667 DOI: 10.1038/Oby.2002.168  0.336
2002 Lerman C, Shields PG, Wileyto EP, Audrain J, Pinto A, Hawk L, Krishnan S, Niaura R, Epstein L. Pharmacogenetic investigation of smoking cessation treatment Pharmacogenetics. 12: 627-634. PMID 12439223 DOI: 10.1097/00008571-200211000-00007  0.528
2002 Lerman C, Niaura R. Applying genetic approaches to the treatment of nicotine dependence. Oncogene. 21: 7412-7420. PMID 12379882 DOI: 10.1038/Sj.Onc.1205801  0.508
2002 Tercyak KP, Lerman C, Audrain J. Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 41: 799-805. PMID 12108804 DOI: 10.1097/00004583-200207000-00011  0.479
2002 Lerman C, Roth D, Kaufmann V, Audrain J, Hawk L, Liu A, Niaura R, Epstein L. Mediating mechanisms for the impact of bupropion in smoking cessation treatment Drug and Alcohol Dependence. 67: 219-223. PMID 12095672 DOI: 10.1016/S0376-8716(02)00067-4  0.447
2001 Lerman C, Audrain J, Tercyak K, Hawk LW, Bush A, Crystal-Mansour S, Rose C, Niaura R, Epstein LH. Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 3: 353-9. PMID 11694203 DOI: 10.1080/14622200110072156  0.457
2001 Lerman C, Caporaso NE, Bush A, Zheng YL, Audrain J, Main D, Shields PG. Tryptophan hydroxylase gene variant and smoking behavior American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 518-520. PMID 11496367 DOI: 10.1002/Ajmg.1476  0.506
2001 Marteau TM, Lerman C. Genetic risk and behavioural change Bmj. 322: 1056-1059. PMID 11325776 DOI: 10.1136/Bmj.322.7293.1056  0.303
2000 Lerman C, Caporaso NE, Audrain J, Main D, Boyd NR, Shields PG. Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence Molecular Psychiatry. 5: 189-192. PMID 10822347 DOI: 10.1038/Sj.Mp.4000672  0.509
1999 Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, Boyd NR, Shields PG. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychology. 18: 14-20. PMID 9925041 DOI: 10.1037/0278-6133.18.1.14  0.512
1998 Brunet JS, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R, Liede A, Futreal PA, et al. Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. Journal of the National Cancer Institute. 90: 761-6. PMID 9605646 DOI: 10.1093/Jnci/90.10.761  0.364
1998 Lerman C, Caporaso N, Main D, Audrain J, Boyd NR, Bowman ED, Shields PG. Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health Psychology. 17: 56-62. PMID 9459071 DOI: 10.1037//0278-6133.17.1.56  0.465
1998 Audrain J, Lerman C, Gomez-Caminero A, Boyd NR, Orleans CT. The Role of Trait Anxiety in Nicotine Dependence1 Journal of Applied Biobehavioral Research. 3: 29-42. DOI: 10.1111/J.1751-9861.1998.Tb00042.X  0.45
1998 Lerman C, Main D, Audrain J, Caporaso NE, Bowman ED, Lockshin B, Shields PG, Boyd NR. Evidence Suggesting The Role Of Specific Genetic Factors In Cigarette Smoking Psychosomatic Medicine. 60: 104. DOI: 10.1097/00006842-199801000-00068  0.473
1997 Lerman C, Shields PG, Main D, Audrain J, Roth J, Boyd NR, Caporaso NE. Lack of association of tyrosine hydroxylase genetic polymorphism with cigarette smoking. Pharmacogenetics. 7: 521-524. PMID 9429239 DOI: 10.1097/00008571-199712000-00012  0.485
1997 Audrain J, Boyd NR, Roth J, Main D, Caporaso NE, Lerman C. Genetic susceptibility testing in smoking-cessation treatment: One-year outcomes of a randomized trial Addictive Behaviors. 22: 741-751. PMID 9426791 DOI: 10.1016/S0306-4603(97)00060-9  0.5
1997 Lerman C, Gold K, Audrain J, Lin TH, Orleans CT, Boyd NR, Wilfond B, Louben G, Caporaso N. Incorporating Biomarkers of Exposure and Genetic Susceptibility into Smoking Cessation Treatment: Effects on Smoking-Related Cognitions, Emotions, and Behavior Change Health Psychology. 16: 87-99. PMID 9028818 DOI: 10.1037//0278-6133.16.1.87  0.501
1996 Lerman C, Audrain J, Orleans CT, Boyd R, Gold K, Main D, Caporaso N. Investigation of mechanisms linking depressed mood to nicotine dependence Addictive Behaviors. 21: 9-19. PMID 8729703 DOI: 10.1016/0306-4603(95)00032-1  0.473
Low-probability matches (unlikely to be authored by this person)
2009 Baker TB, Cummings KM, Hatsukami DK, Johnson CA, Lerman C, Niaura R, O'Malley SS. Transdisciplinary Tobacco Use Research Centers: research achievements and future implications. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 1231-44. PMID 19633277 DOI: 10.1093/Ntr/Ntp112  0.294
2011 Mrazek DA, Lerman C. Facilitating clinical implementation of pharmacogenomics. Jama. 306: 304-5. PMID 21771991 DOI: 10.1001/Jama.2011.1010  0.294
1996 Lerman C, Schulman K, Narod S, Lynch H. Genetic Testing of Families With Hereditary Diseases-Reply Jama. 276: 1140-1140. DOI: 10.1001/Jama.1996.03540140028019  0.293
2000 Lerman C, Hughes C, Croyle RT, Main D, Durham C, Snyder C, Bonney A, Lynch JF, Narod SA, Lynch HT. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Preventive Medicine. 31: 75-80. PMID 10896846 DOI: 10.1006/Pmed.2000.0684  0.293
1999 Lynch HT, Watson P, Tinley S, Snyder C, Durham C, Lynch J, Kirnarsky Y, Serova O, Lenoir G, Lerman C, Narod SA. An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer. Cancer Genetics and Cytogenetics. 109: 91-8. PMID 10087939 DOI: 10.1016/S0165-4608(98)00165-4  0.29
1995 Lerman C, Seay J, Balshem A, Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. American Journal of Medical Genetics. 57: 385-392. PMID 7677139 DOI: 10.1002/Ajmg.1320570304  0.29
1994 Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. Journal of Clinical Oncology. 12: 843-850. PMID 8151327 DOI: 10.1200/Jco.1994.12.4.843  0.29
2017 Peng AR, Le Foll B, Morales M, Lerman C, Schnoll R, Tyndale RF. Improvement of the association between self-reported pill count and varenicline levels following exclusion of participants with misreported pill count: A commentary on Peng et al. (2017). Addictive Behaviors. 79: 14-16. PMID 29232593 DOI: 10.1016/J.Addbeh.2017.11.032  0.29
1997 Lerman C, Schwartz MD, Lin TH, Hughes C, Narod S, Lynch HT. The influence of psychological distress on use of genetic testing for cancer risk. Journal of Consulting and Clinical Psychology. 65: 414-20. PMID 9170764 DOI: 10.1037//0022-006X.65.3.414  0.289
1996 Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, et al. BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes Journal of the American Medical Association. 275: 1885-1892. PMID 8648868 DOI: 10.1001/Jama.275.24.1885  0.289
1997 Lerman C. Translational Behavioral Research In Cancer Genetics Preventive Medicine. 26: 65-69. PMID 9327494 DOI: 10.1006/Pmed.1997.0204  0.288
2004 Lerman C, Shields AE. Genetic testing for cancer susceptibility: the promise and the pitfalls. Nature Reviews Cancer. 4: 235-241. PMID 14993905 DOI: 10.1038/Nrc1301  0.287
2002 Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD, Wenzel L, Lemke A, Marcus AC, Lerman C. A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychology. 21: 564-572. DOI: 10.1037/0278-6133.21.6.564  0.286
2004 McInerney-Leo A, Biesecker BB, Hadley DW, Kase RG, Giambarresi TR, Johnson E, Lerman C, Struewing JP. BRCA1/2 testing in hereditary breast and ovarian cancer families: Effectiveness of problem-solving training as a counseling intervention American Journal of Medical Genetics Part A. 130: 221-227. PMID 15378542 DOI: 10.1002/Ajmg.A.30265  0.286
2002 Lerman C, Croyle RT, Tercyak KP, Hamann H. Genetic testing: psychological aspects and implications. Journal of Consulting and Clinical Psychology. 70: 784-97. PMID 12090383 DOI: 10.1037/0022-006X.70.3.784  0.285
1999 Lerman C, Hughes C, Trock BJ, Myers RE, Main D, Bonney A, Abbaszadegan MR, Harty AE, Franklin BA, Lynch JF, Lynch HT. Genetic testing in families with hereditary nonpolyposis colon cancer Journal of the American Medical Association. 281: 1618-1622. PMID 10235155 DOI: 10.1001/Jama.281.17.1618  0.284
2001 Tercyak KP, Lerman C, Peshkin BN, Hughes C, Main D, Isaacs C, Schwartz MD. Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychology. 20: 217-222. DOI: 10.1037/0278-6133.20.3.217  0.284
2000 Biesecker BB, Ishibe N, Hadley DW, Giambarresi TR, Kase RG, Lerman C, Struewing JP. Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families American Journal of Medical Genetics. 93: 257-263. PMID 10946349 DOI: 10.1002/1096-8628(20000814)93:4<257::Aid-Ajmg1>3.0.Co;2-8  0.283
2005 Schwartz MD, Lerman C, Brogan B, Peshkin BN, Isaacs C, DeMarco T, Halbert CH, Pennanen M, Finch C. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 1003-7. PMID 15824179 DOI: 10.1158/1055-9965.Epi-03-0545  0.283
2001 Peshkin BN, DeMarco TA, Brogan BM, Lerman C, Isaacs C. BRCA1/2 testing: Complex themes in result interpretation Journal of Clinical Oncology. 19: 2555-2565. PMID 11331335 DOI: 10.1200/Jco.2001.19.9.2555  0.282
1997 Croyle RT, Achilles JS, Lerman C. Psychologic aspects of cancer genetic testing: a research update for clinicians. Cancer. 80: 569-575. DOI: 10.1002/(Sici)1097-0142(19970801)80:3+<569::Aid-Cncr6>3.0.Co;2-4  0.281
2004 Halbert CH, Lynch H, Lynch J, Main D, Kucharski S, Rustgi AK, Lerman C. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations Archives of Internal Medicine. 164: 1881-1887. PMID 15451763 DOI: 10.1001/Archinte.164.17.1881  0.281
1996 Lerman C, Marshall J, Audrain J, Gomez-Caminero A. Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers International Journal of Cancer. 69: 58-61. PMID 8600064 DOI: 10.1002/(Sici)1097-0215(19960220)69:1<58::Aid-Ijc15>3.0.Co;2-G  0.28
1998 Rimer BK, Sugarman J, Winer E, Bluman LG, Lerman C. Informed consent for BRCA1 and BRCA2 testing Breast Disease. 10: 99-114. PMID 15687553 DOI: 10.3233/Bd-1998-101-212  0.279
1999 Croyle RT, Lerman C. Risk communication in genetic testing for cancer susceptibility. Journal of the National Cancer Institute Monographs. 1999: 59-66. PMID 10854459 DOI: 10.1093/Oxfordjournals.Jncimonographs.A024210  0.279
1997 Hughes C, Gomez-Caminero A, Benkendorf J, Kerner J, Isaacs C, Barter J, Lerman C. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk Patient Education and Counseling. 32: 51-62. PMID 9355572 DOI: 10.1016/S0738-3991(97)00064-5  0.279
2011 Zhao X, Strasser A, Cappella JN, Lerman C, Fishbein M. A Measure of Perceived Argument Strength: Reliability and Validity. Communication Methods and Measures. 5: 48-75. PMID 25568663 DOI: 10.1080/19312458.2010.547822  0.279
2004 Halbert CH, Schwartz MD, Wenzel L, Narod S, Peshkin BN, Cella D, Lerman C. Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations. Journal of Behavioral Medicine. 27: 373-92. PMID 15559734 DOI: 10.1023/B:Jobm.0000042411.56032.42  0.278
1990 Myers RE, Trock BJ, Lerman C, Wolf T, Ross E, Engstrom PF. Adherence to colorectal cancer screening in an HMO population. Preventive Medicine. 19: 502-14. PMID 2235919 DOI: 10.1016/0091-7435(90)90049-P  0.276
1996 Botkin JR, Croyle RT, Smith KR, Baty BJ, Lerman C, Goldgar DE, Ward JM, Flick BJ, Nash JE. A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing Journal of the National Cancer Institute. 88: 872-882. PMID 8656439 DOI: 10.1093/Jnci/88.13.872  0.275
1997 Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing Journal of the National Cancer Institute. 89: 148-157. PMID 8998184 DOI: 10.1093/Jnci/89.2.148  0.275
1997 Benkendorf JL, Reutenauer JE, Hughes CA, Eads N, Willison J, Powers M, Lerman C. Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility. American Journal of Medical Genetics. 73: 296-303. PMID 9415688 DOI: 10.1002/(Sici)1096-8628(19971219)73:3<296::Aid-Ajmg13>3.0.Co;2-E  0.275
2002 Berry DA, Iversen ES, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes Journal of Clinical Oncology. 20: 2701-2712. PMID 12039933 DOI: 10.1200/Jco.2002.05.121  0.275
1999 Audrain J, Rimer B, Cella D, Stefanek M, Garber J, Pennanen M, Helzlsouer K, Vogel V, Lin TH, Lerman C. The impact of a brief coping skills intervention on adherence to breast self-examination among first-degree relatives of newly diagnosed breast cancer patients. Psycho-Oncology. 8: 220-9. PMID 10390734 DOI: 10.1002/(Sici)1099-1611(199905/06)8:3<220::Aid-Pon370>3.0.Co;2-C  0.274
2002 Wilfond BS, Geller G, Lerman C, Audrain-McGovern J, Shields AE. Ethical issues in conducting behavioral genetics research: the case of smoking prevention trials among adolescents. Journal of Health Care Law & Policy. 6: 73-88. PMID 15017952  0.273
1996 Rimer BK, Schildkraut JM, Lerman C, Lin TH, Audrain J. Participation in a women's breast cancer risk counseling trial: Who participates? Who declines? Cancer. 77: 2348-2355. PMID 8635106 DOI: 10.1002/(Sici)1097-0142(19960601)77:11<2348::Aid-Cncr25>3.0.Co;2-W  0.273
1995 Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, Balshem A. Effects of Individualized Breast Cancer Risk Counseling: a Randomized Trial Journal of the National Cancer Institute. 87: 286-292. PMID 7707420 DOI: 10.1093/Jnci/87.4.286  0.273
1994 Lerman C, Croyle R. Psychological Issues in Genetic Testing for Breast Cancer Susceptibility Jama Internal Medicine. 154: 609-616. DOI: 10.1001/Archinte.1994.00420060027003  0.273
2009 Mague SD, Isiegas C, Huang P, Liu-Chen LY, Lerman C, Blendy JA. Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proceedings of the National Academy of Sciences of the United States of America. 106: 10847-52. PMID 19528658 DOI: 10.1073/Pnas.0901800106  0.273
1997 Audrain J, Schwartz MD, Lerman C, Hughes C, Peshkin BN, Biesecker B. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 19: 370-7. PMID 9706364 DOI: 10.1007/Bf02895156  0.272
2003 Botkin JR, Smith KR, Croyle RT, Baty BJ, Wylie JE, Dutson D, Chan A, Hamann HA, Lerman C, McDonald J, Venne V, Ward JH, Lyon E. Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics. Part A. 118: 201-9. PMID 12673648 DOI: 10.1002/Ajmg.A.10102  0.27
1998 Schwartz MD, Lerman C, Audrain J, Cella D, Rimer B, Stefanek M, Garber J, Lin TH, Vogel V. The impact of a brief problem-solving training intervention for relatives of recently diagnosed breast cancer patients. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 20: 7-12. PMID 9755346 DOI: 10.1007/Bf02893803  0.269
2003 Schwartz MD, Kaufman E, Peshkin BN, Isaacs C, Hughes C, DeMarco T, Finch C, Lerman C. Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 4034-41. PMID 14581427 DOI: 10.1200/Jco.2003.01.088  0.269
2009 Saccone SF, Bierut LJ, Chesler EJ, Kalivas PW, Lerman C, Saccone NL, Uhl GR, Li CY, Philip VM, Edenberg HJ, Sherry ST, Feolo M, Moyzis RK, Rutter JL. Supplementing high-density SNP microarrays for additional coverage of disease-related genes: addiction as a paradigm. Plos One. 4: e5225. PMID 19381300 DOI: 10.1371/Journal.Pone.0005225  0.268
1991 Rimer BK, Glanz K, Lerman C. Contributions of public health to patient compliance. Journal of Community Health. 16: 225-240. PMID 1918439 DOI: 10.1007/Bf01324390  0.267
2001 Tercyak KP, Peshkin BN, Streisand R, Lerman C. Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants Psycho-Oncology. 10: 336-346. PMID 11462232 DOI: 10.1002/Pon.531  0.266
1994 Lerman C, Audrain J, Croyle RT. DNA-Testing for Heritable Breast Cancer Risks: Lessons from Traditional Genetic Counseling Annals of Behavioral Medicine. 16: 327-333. DOI: 10.1093/Abm/16.4.327  0.265
1993 Lerman C, Schwartz M. Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Research and Treatment. 28: 145-155. PMID 8173067 DOI: 10.1007/Bf00666427  0.265
2004 Lessov CN, Swan GE, Ring HZ, Khroyan TV, Lerman C. Genetics and drug use as a complex phenotype. Substance Use & Misuse. 39: 1515-69. PMID 15587945 DOI: 10.1081/Ja-200033202  0.265
1991 Lerman C, Rimer BK, Engstrom PF. Cancer risk notification: psychosocial and ethical implications. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 9: 1275-82. PMID 2045867 DOI: 10.1200/Jco.1991.9.7.1275  0.265
1999 Lynch HT, Watson P, Shaw TG, Lynch JF, Harty AE, Franklin BA, Kapler CR, Tinley ST, Liu B, Lerman C. Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer: Part II: Hereditary nonpolyposis colorectal carcinoma as a model Cancer. 86: 2457-2463. PMID 10630171 DOI: 10.1002/(Sici)1097-0142(19991201)86:11+<2457::Aid-Cncr2>3.0.Co;2-I  0.264
1999 Stefanek M, Enger C, Benkendorf J, Honig SF, Lerman C. Bilateral prophylactic mastectomy decision making: A vignette study. Preventive Medicine. 29: 216-221. PMID 10479610 DOI: 10.1006/Pmed.1999.0524  0.264
2009 Langleben DD, Loughead JW, Ruparel K, Hakun JG, Busch-Winokur S, Holloway MB, Strasser AA, Cappella JN, Lerman C. Reduced prefrontal and temporal processing and recall of high "sensation value" ads. Neuroimage. 46: 219-25. PMID 19457412 DOI: 10.1016/J.Neuroimage.2008.12.062  0.264
2010 Shim M, Cappella JN, Lerman C. Familial risk cues in direct-to-consumer prescription drug advertisements: Impacts on intentions to adopt healthy lifestyles and pharmaceutical choices Journal of Applied Communication Research. 38: 230-247. DOI: 10.1080/00909882.2010.490842  0.264
1992 Glanz K, Resch N, Lerman C, Blake A, Gorchov PMG, Rimer BK. Factors associated with adherence to breast cancer screening among working women. Journal of Occupational and Environmental Medicine. 34: 1071-1078. PMID 1432296 DOI: 10.1097/00043764-199211000-00008  0.263
2002 Lerman C, Swan GE. Non-replication of genetic association studies: is DAT all, folks? Nicotine & Tobacco Research. 4: 247-249. PMID 12215232 DOI: 10.1080/14622200210141220  0.263
1998 Audrain J, Rimer B, Cella D, Garber J, Peshkin BN, Ellis J, Schildkraut J, Stefanek M, Vogel V, Lerman C. Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 133-8. PMID 9440734 DOI: 10.1200/Jco.1998.16.1.133  0.263
1998 Lerman C, Hughes C, Lemon SJ, Main D, Snyder C, Durham C, Narod S, Lynch HT. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 1650-4. PMID 9586874 DOI: 10.1200/Jco.1998.16.5.1650  0.262
2005 McInerney-Leo A, Biesecker BB, Hadley DW, Kase RG, Giambarresi TR, Johnson E, Lerman C, Struewing JP. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships. American Journal of Medical Genetics Part A. 133: 165-169. PMID 15633195 DOI: 10.1002/Ajmg.A.30566  0.262
2011 Perkins KA, Lerman C. Early human screening of medications to treat drug addiction: novel paradigms and the relevance of pharmacogenetics. Clinical Pharmacology and Therapeutics. 89: 460-3. PMID 21270792 DOI: 10.1038/Clpt.2010.254  0.26
1999 Schwartz MD, Rimer BK, Daly M, Sands C, Lerman C. A randomized trial of breast cancer risk counseling: the impact on self-reported mammography use. American Journal of Public Health. 89: 924-6. PMID 10358689 DOI: 10.2105/Ajph.89.6.924  0.26
1999 Burnett CB, Steakley CS, Slack R, Roth J, Lerman C. Patterns of breast cancer screening among lesbians at increased risk for breast cancer. Women & Health. 29: 35-55. PMID 10608668 DOI: 10.1300/J013V29N04_03  0.259
1999 Peshkin BN, Lerman C. Genetic counselling for hereditary breast cancer The Lancet. 353: 2176-2177. PMID 10392978 DOI: 10.1016/S0140-6736(99)90078-8  0.259
2001 Schwartz MD, Rothenberg K, Joseph L, Benkendorf J, Lerman C. Consent to the use of stored DNA for genetics research: a survey of attitudes in the Jewish population. American Journal of Medical Genetics. 98: 336-42. PMID 11170078 DOI: 10.1002/1096-8628(20010201)98:4<336::Aid-Ajmg1100>3.0.Co;2-7  0.258
2004 Manne S, Audrain J, Schwartz M, Main D, Finch C, Lerman C. Associations between relationship support and psychological reactions of participants and partners to BRCA1 and BRCA2 testing in a clinic-based sample. Annals of Behavioral Medicine. 28: 211-225. PMID 15576260 DOI: 10.1207/S15324796Abm2803_10  0.257
2005 Frosch DL, Mello P, Lerman C. Behavioral Consequences of Testing for Obesity Risk Cancer Epidemiology, Biomarkers & Prevention. 14: 1485-1489. PMID 15941960 DOI: 10.1158/1055-9965.Epi-04-0913  0.257
2004 Schwartz MD, Lerman C, Brogan B, Peshkin BN, Halbert CH, DeMarco T, Lawrence W, Main D, Finch C, Magnant C, Pennanen M, Tsangaris T, Willey S, Isaacs C. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1823-9. PMID 15067026 DOI: 10.1200/Jco.2004.04.086  0.257
2002 Isaacs C, Peshkin BN, Schwartz M, Demarco TA, Main D, Lerman C. Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Research and Treatment. 71: 103-12. PMID 11881908 DOI: 10.1023/A:1013800409238  0.257
1993 King ES, Resch N, Rimer B, Lerman C, Boyce A, McGovern-Gorchov P. Breast Cancer Screening Practices Among Retirement Community Women Preventive Medicine. 22: 1-19. PMID 8475006 DOI: 10.1006/Pmed.1993.1001  0.256
2009 Stefanek ME, Andrykowski MA, Lerman C, Manne S, Glanz K. Behavioral oncology and the war on cancer: partnering with biomedicine. Cancer Research. 69: 7151-6. PMID 19706775 DOI: 10.1158/0008-5472.Can-08-4005  0.256
1990 Lerman C, Rimer B, Trock B, Balshem A, Engstrom PF. Factors associated with repeat adherence to breast cancer screening. Preventive Medicine. 19: 279-90. PMID 2377590 DOI: 10.1016/0091-7435(90)90028-I  0.256
1996 Lerman C, Schwartz MD, Miller SM, Daly M, Sands C, Rimer BK. A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 15: 75-83. PMID 8681923 DOI: 10.1037/0278-6133.15.2.75  0.256
1996 Hughes C, Lerman C, Lustbader E. Ethnic differences in risk perception among women at increased risk for breast cancer Breast Cancer Research and Treatment. 40: 25-35. PMID 8888150 DOI: 10.1007/Bf01806000  0.255
1997 Epstein SA, Lin TH, Audrain J, Stefanek ME, Rimer B, Lerman C. Excessive Breast Self-Examination Among First-Degree Relatives of Newly Diagnosed Breast Cancer Patients Psychosomatics. 38: 253-261. PMID 9136254 DOI: 10.1016/S0033-3182(97)71462-2  0.255
2018 Jung WH, Lee S, Lerman C, Kable JW. Amygdala Functional and Structural Connectivity Predicts Individual Risk Tolerance. Neuron. PMID 29628186 DOI: 10.1016/J.Neuron.2018.03.019  0.253
1997 Miller SM, Siejak KK, Schroeder CM, Lerman C, Hernandez E, Helm CW. Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy. Journal of the National Cancer Institute. 89: 703-8. PMID 9168185 DOI: 10.1093/Jnci/89.10.703  0.253
2021 El-Boraie A, Tanner JA, Zhu AZX, Claw KG, Prasad B, Schuetz EG, Thummel KE, Fukunaga K, Mushiroda T, Kubo M, Benowitz NL, Lerman C, Tyndale RF. Functional Characterization Of Novel Rare CYP2A6 Variants And Potential Implications For Clinical Outcomes. Clinical and Translational Science. PMID 34476898 DOI: 10.1111/cts.13135  0.253
2015 Webb A, Papp AC, Curtis A, Newman LC, Pietrzak M, Seweryn M, Handelman SK, Rempala GA, Wang D, Graziosa E, Tyndale RF, Lerman C, Kelsoe JR, Mash DC, Sadee W. RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles. Bmc Genomics. 16: 990. PMID 26597164 DOI: 10.1186/S12864-015-2207-8  0.253
2000 Tercyak KP, Streisand R, Peshkin BN, Lerman C. Psychosocial Impact of Predictive Testing for Illness on Children and Families: Challenges for a New Millennium Journal of Clinical Psychology in Medical Settings. 7: 55-68. DOI: 10.1023/A:1009597303743  0.253
1990 Lerman C, Rimer B, Blumberg B, Cristinzio S, Engstrom PF, MacElwee N, O??Connor K, Seay J. Effects of coping style and relaxation on cancer chemotherapy side effects and emotional responses Cancer Nursing. 13: 308???315. DOI: 10.1097/00002820-199010000-00006  0.253
1997 Lerman C, Peters JA, Ades T, Fink D, Barr P, Biesecker BB, Brooks SW, Calzone KA, Croyle RT, Fine BA, Green B, Lemon SJ, Lynch HT, Narod SA, Offit K, et al. Genetic counseling issues Cancer. 80: 628-629. DOI: 10.1002/(Sici)1097-0142(19970801)80:3+<628::Aid-Cncr14>3.0.Co;2-G  0.251
1999 Jernström H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, Daly M, Olopade OI, Foulkes WD, Warner E, Brunet JS, Narod SA. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. The Lancet. 354: 1846-1850. PMID 10584720 DOI: 10.1016/S0140-6736(99)04336-6  0.251
1997 Lynch HT, Lemon SJ, Durham C, Tinley ST, Connolly C, Lynch JF, Surdam J, Orinion E, Slominski-Caster S, Watson P, Lerman C, Tonin P, Lenoir G, Serova O, Narod S. A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer. 79: 2219-28. PMID 9179070 DOI: 10.1002/(Sici)1097-0142(19970601)79:11<2219::Aid-Cncr21>3.0.Co;2-Y  0.251
1991 Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A. Psychological side effects of breast cancer screening. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 10: 259-67. PMID 1915212 DOI: 10.1037//0278-6133.10.4.259  0.251
2021 Chenoweth MJ, Cox LS, Nollen NL, Ahluwalia JS, Benowitz NL, Lerman C, Knight J, Tyndale RF. Analyses of nicotine metabolism biomarker genetics stratified by sex in African and European Americans. Scientific Reports. 11: 19572. PMID 34599228 DOI: 10.1038/s41598-021-98883-z  0.251
1996 Glanz K, Resch N, Lerman C, Rimer BK. Black-white differences in factors influencing mammography use among employed female health maintenance organization members. Ethnicity & Health. 1: 207-220. PMID 9395565 DOI: 10.1080/13557858.1996.9961789  0.25
2000 Halverson PK, Mays GP, Rimer BK, Lerman C, Audrain J, Kaluzny AD. Adoption of a health education intervention for family members of breast cancer patients American Journal of Preventive Medicine. 18: 189-198. PMID 10722984 DOI: 10.1016/S0749-3797(99)00163-4  0.249
2002 Tercyak KP, Peshkin BN, DeMarco TA, Brogan BM, Lerman C. Parent-child factors and their effect on communicating BRCA1/2 test results to children Patient Education and Counseling. 47: 145-153. PMID 12191538 DOI: 10.1016/S0738-3991(01)00192-6  0.248
2008 Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM. Cancer epidemiology, biomarkers & prevention and cancer prevention research: two journals, a common goal. Cancer Prevention Research (Philadelphia, Pa.). 1: 393-5. PMID 19138984 DOI: 10.1158/1940-6207.Capr-08-0176  0.246
2008 Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM. Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goal. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2903-5. PMID 18990728 DOI: 10.1158/1055-9965.Epi-08-0888  0.246
1991 Lerman C, Miller SM, Scarborough R, Hanjani P, Nolte S, Smith D. Adverse psychologic consequences of positive cytologic cervical screening. American Journal of Obstetrics and Gynecology. 165: 658-62. PMID 1892194 DOI: 10.1016/0002-9378(91)90304-A  0.246
1990 Lerman C, Caputo C, Brody D. Factors associated with inadequate cervical cancer screening among lower income primary care patients. Journal of the American Board of Family Practice. 3: 151-156. DOI: 10.3122/Jabfm.3.3.151  0.246
1995 Schwartz MD, Lerman C, Miller SM, Daly M, Masny A. Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 14: 232-5. PMID 7641664 DOI: 10.1037/0278-6133.14.3.232  0.246
1993 Lerman C, Daly M, Sands C, Balshem A, Lustbader E, Heggan T, Goldstein L, James J, Engstrom P. Mammography adherence and psychological distress among women at risk for breast cancer. Journal of the National Cancer Institute. 85: 1074-80. PMID 8515494 DOI: 10.1093/Jnci/85.13.1074  0.245
1997 Lerman C, Rimer B, Glynn T. Priorities in behavioral research in cancer prevention and control Preventive Medicine. 26. PMID 9327487 DOI: 10.1006/Pmed.1997.0211  0.245
1997 Lerman C. Psychological aspects of genetic testing: Introduction to the special issue. Health Psychology. 16: 3-7. DOI: 10.1037/H0092702  0.245
2001 Tercyak KP, Hughes C, Main D, Snyder C, Lynch JF, Lynch HT, Lerman C. Parental communication of BRCA1/2 genetic test results to children. Patient Education and Counseling. 42: 213-24. PMID 11164320 DOI: 10.1016/S0738-3991(00)00122-1  0.245
1990 Rimer BK, Trock B, Balshem A, Engstrom PF, Rosan J, Lerman C. Breast screening practices among primary physicians: reality and potential. Journal of the American Board of Family Practice. 3: 26-34. DOI: 10.3122/Jabfm.3.1.26  0.245
2001 Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet (London, England). 356: 1876-81. PMID 11130383 DOI: 10.1016/S0140-6736(00)03258-X  0.24
1993 Lerman C, Daly M, Walsh WP, Resch N, Seay J, Barsevick A, Birenbaum L, Heggan T, Martin G. Communication between patients with breast cancer and health care providers. Determinants and implications. Cancer. 72: 2612-20. PMID 8402483 DOI: 10.1002/1097-0142(19931101)72:9<2612::Aid-Cncr2820720916>3.0.Co;2-F  0.238
1992 Glanz K, Lerman C. Psychosocial impact of breast cancer: A critical review. Annals of Behavioral Medicine. 14: 204-212. DOI: 10.1093/Abm/14.3.204  0.236
1991 Rimer BK, Trock B, Engstrom PF, Lerman C, King E. Why do some women get regular mammograms American Journal of Preventive Medicine. 7: 69-74. DOI: 10.1016/S0749-3797(18)30940-1  0.236
2002 Hughes C, Lerman C, Schwartz M, Peshkin BN, Wenzel L, Narod S, Corio C, Tercyak KP, Hanna D, Isaacs C, Main D. All in the family: Evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results American Journal of Medical Genetics. 107: 143-150. PMID 11807889 DOI: 10.1002/Ajmg.10110  0.235
2004 Epstein LH, Wright SM, Paluch RA, Leddy JJ, Hawk LW, Jaroni JL, Saad FG, Crystal-Mansour S, Shields PG, Lerman C. Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. The American Journal of Clinical Nutrition. 80: 82-8. PMID 15213032 DOI: 10.1093/Ajcn/80.1.82  0.233
2022 Leventhal AM, Cho J, Vogel EA, Tackett AP, Harlow AF, Wong M, Han DH, Hughes Halbert C, Unger J, Lerman C, Barrington-Trimis JL. Differences in intention to use flavored oral nicotine products among young adult e-cigarette users and non-users. Preventive Medicine Reports. 30: 102027. PMID 36304078 DOI: 10.1016/j.pmedr.2022.102027  0.232
2001 Schwartz MD, Benkendorf J, Lerman C, Isaacs C, Ryan-Robertson A, Johnson L. Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women. Cancer. 92: 932-40. PMID 11550168 DOI: 10.1002/1097-0142(20010815)92:4<932::Aid-Cncr1403>3.0.Co;2-Q  0.232
1991 Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral implications of abnormal mammograms. Annals of Internal Medicine. 114: 657-61. PMID 2003712 DOI: 10.7326/0003-4819-114-8-657  0.228
1992 Lerman C, Ross E, Boyce A, Gorchov PM, McLaughlin R, Rimer B, Engstrom P. The impact of mailing psychoeducational materials to women with abnormal mammograms. American Journal of Public Health. 82: 729-30. PMID 1566953 DOI: 10.2105/Ajph.82.5.729  0.227
1992 Lerman C, Hanjani P, Caputo C, Miller S, Delmoor E, Nolte S, Engstrom P. Telephone counseling improves adherence to colposcopy among lower-income minority women. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 10: 330-3. PMID 1732434 DOI: 10.1200/Jco.1992.10.2.330  0.226
2004 Leddy JJ, Epstein LH, Jaroni JL, Roemmich JN, Paluch RA, Goldfield GS, Lerman C. Influence of methylphenidate on eating in obese men. Obesity Research. 12: 224-32. PMID 14981214 DOI: 10.1038/Oby.2004.29  0.222
1992 Brody DS, Lerman C, Jemmott JB. AIDS concerns among low-risk heterosexuals: the other side of the epidemic. Medical Care. 30: 276-281. PMID 1538615 DOI: 10.1097/00005650-199203000-00009  0.221
2004 Epstein LH, Wright SM, Paluch RA, Leddy J, Hawk LW, Jaroni JL, Saad FG, Crystal-Mansour S, Lerman C. Food hedonics and reinforcement as determinants of laboratory food intake in smokers. Physiology & Behavior. 81: 511-7. PMID 15135024 DOI: 10.1016/J.Physbeh.2004.02.015  0.218
2004 Wileyto EP, Audrain-McGovern J, Epstein LH, Lerman C. Using logistic regression to estimate delay-discounting functions. Behavior Research Methods, Instruments, & Computers : a Journal of the Psychonomic Society, Inc. 36: 41-51. PMID 15190698 DOI: 10.3758/Bf03195548  0.212
1997 Epstein SA, Lerman C. Excessive health behaviors in those at risk for physical disorder. Journal of Psychosomatic Research. 43: 223-225. PMID 9304547 DOI: 10.1016/S0022-3999(97)00017-2  0.205
2007 Schnoll RA, Wileyto EP, Hornik R, Schiller J, Lerman C. Spiral computed tomography and lung cancer: science, the media, and public opinion. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5695-7. PMID 18089863 DOI: 10.1200/Jco.2007.13.5228  0.203
2010 Chiamulera C, Lerman C, Pogun S. A new chapter in the history of SRNT: the formation of the European chapter of SRNT (SRNT-E)--a letter from the Presidents of SRNT and SRNT Europe. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 12: 1181-2. PMID 21059819 DOI: 10.1093/Ntr/Ntq180  0.201
2022 Tackett AP, Wong M, Cho J, Harlow AF, Vogel EA, Han DH, Barrington-Trimis JL, McConnell R, Budney AJ, Audrain-McGovern JE, Lerman C, Monterosso J, Leventhal AM. Willingness to Use Commercial Nicotine Gums, Lozenges, and Gummies Among Nontobacco Using Adolescents in Southern California. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. PMID 36470691 DOI: 10.1016/j.jadohealth.2022.09.027  0.199
2018 Lerman C, Jameson JL. Leadership Development in Medicine. The New England Journal of Medicine. 378: 1862-1863. PMID 29768144 DOI: 10.1056/Nejmp1801610  0.191
2004 Lerman C, Kaufman V, Rukstalis M, Patterson F, Audrian-McGobern J, Benowitx N, Córdoba García R. Individualización de la terapia de nicotina en el tratamiento del tabaquismo Fmc - FormacióN MéDica Continuada En AtencióN Primaria. 11: 518. DOI: 10.1016/S1134-2072(04)76199-X  0.167
2002 Peshkin BN, Schwartz MD, Isaacs C, Hughes C, Main D, Lerman C. Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 1115-8. PMID 12376518  0.146
2002 Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD, Wenzel L, Lemke A, Marcus AC, Lerman C. A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 21: 564-72. PMID 12433008  0.145
2023 Koban L, Lee S, Schelski DS, Simon MC, Lerman C, Weber B, Kable JW, Plassmann H. An fMRI-based brain marker of individual differences in delay discounting. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 36657973 DOI: 10.1523/JNEUROSCI.1343-22.2022  0.138
2023 Chang EY, Solomon I, Culver JO, Gorman N, Comeaux JG, Lerman C, Quinn EA, Ekstein T. Clinical and laboratory genetic counselor attitudes on the reporting of variants of uncertain significance for multigene cancer panels. Journal of Genetic Counseling. PMID 36747331 DOI: 10.1002/jgc4.1680  0.127
1999 Croyle RT, Achilles JS, Lerman C. Psychologic aspects of cancer genetic testing: a research update for clinicians. Cancer. 80: 569-75. PMID 11657060 DOI: 10.1002/(sici)1097-0142(19970801)80:3+<569::aid-cncr6>3.3.co;2-9  0.122
2022 Culver JO, Freiberg Y, Ricker C, Comeaux JG, Chang EY, Banerjee V, Sturgeon D, Solomon I, Kagey J, Dobre MG, Carey J, Carr A, Cho S, Lu J, Kang IM, ... ... Lerman C, et al. Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients. Annals of Surgical Oncology. PMID 36161375 DOI: 10.1245/s10434-022-12595-w  0.118
2004 Halbert CH, Wenzel L, Lerman C, Peshkin BN, Narod S, Marcus A, Corio C, Demarco T, Bellamy S. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 875-81. PMID 15159322  0.117
2022 Culver JO, Freiberg Y, Ricker C, Comeaux JG, Chang EY, Banerjee V, Sturgeon D, Solomon I, Kagey J, Dobre MG, Carey J, Carr A, Cho S, Lu J, Kang IM, ... ... Lerman C, et al. ASO Visual Abstract: Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients. Annals of Surgical Oncology. PMID 36319870 DOI: 10.1245/s10434-022-12712-9  0.108
2002 Schwartz MD, Peshkin BN, Hughes C, Main D, Isaacs C, Lerman C. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 514-20. PMID 11786581  0.106
2022 Comeaux JG, Culver JO, Lee JE, Dondanville D, McArthur HL, Quinn E, Gorman N, Ricker C, Li M, Lerman C. Risk-reducing mastectomy decisions among women with mutations in high- and moderate- penetrance breast cancer susceptibility genes. Molecular Genetics & Genomic Medicine. e2031. PMID 36054727 DOI: 10.1002/mgg3.2031  0.102
2022 Navarro S, Yang Y, Ochoa CY, Mejia A, Kim SE, Liu L, Lerman C, Farias AJ. Asian Ethnic Subgroup Disparities in Delays of Surgical Treatment for Breast Cancer. Jnci Cancer Spectrum. 6: pkab089. PMID 35047750 DOI: 10.1093/jncics/pkab089  0.094
2022 Langlois AWR, El-Boraie A, Fukunaga K, Mushiroda T, Kubo M, Lerman C, Knight J, Scherer SE, Chenoweth MJ, Tyndale RF. Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes. Pharmacogenetics and Genomics. PMID 35190513 DOI: 10.1097/FPC.0000000000000466  0.092
2003 Sabichi AL, Demierre MF, Hawk ET, Lerman CE, Lippman SM. Frontiers in cancer prevention research. Cancer Research. 63: 5649-55. PMID 14522879  0.087
2020 Culver JO, Ricker CN, Bonner J, Kidd J, Sturgeon D, Hodan R, Kingham K, Lowstuter K, Chun NM, Lebensohn AP, Rowe-Teeter C, Levonian P, Partynski K, Lara-Otero K, Hong C, ... ... Lerman C, et al. Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients. Cancer. PMID 33320347 DOI: 10.1002/cncr.33357  0.086
2023 Bergström F, Lerman C, Kable JW. Less cortical complexity in ventromedial prefrontal cortex is associated with a greater preference for risky and immediate rewards. Biorxiv : the Preprint Server For Biology. PMID 37745594 DOI: 10.1101/2023.09.12.557368  0.083
2022 Lee S, Parthasarathi T, Cooper N, Zauberman G, Lerman C, Kable JW. A neural signature of the vividness of prospective thought is modulated by temporal proximity during intertemporal decision making. Proceedings of the National Academy of Sciences of the United States of America. 119: e2214072119. PMID 36279433 DOI: 10.1073/pnas.2214072119  0.079
2022 Leader AE, McNair C, Yurick C, Huesser M, Schade E, Stimmel EE, Lerman C, Knudsen KE. Assessing the Coverage of U.S. Cancer Center Primary Catchment Areas. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35064067 DOI: 10.1158/1055-9965.EPI-21-1097  0.075
1987 Lerman CE. Rheumatoid arthritis: Psychological factors in the etiology, course, and treatment Clinical Psychology Review. 7: 413-425. DOI: 10.1016/0272-7358(87)90019-5  0.069
2018 Hromas R, Leverence R, Mramba LK, Jameson JL, Lerman C, Schwenk TL, Zimmermann EM, Good ML. What a medical school chair wants from the dean. Journal of Healthcare Leadership. 10: 33-44. PMID 29872359 DOI: 10.2147/JHL.S158937  0.068
1990 Lerman CE, Brody DS, Caputo GC, Smith DG, Lazaro CG, Wolfson HG. Patients' Perceived Involvement in Care Scale: relationship to attitudes about illness and medical care. Journal of General Internal Medicine. 5: 29-33. PMID 2299426 DOI: 10.1007/BF02602306  0.067
1990 Brody DS, Miller SM, Lerman CE, Smith DG, Caputo GC. Patient perception of involvement in medical care: relationship to illness attitudes and outcomes. Journal of General Internal Medicine. 4: 506-11. PMID 2585158 DOI: 10.1007/BF02599549  0.065
1989 Brody DS, Miller SM, Lerman CE, Smith DG, Lazaro CG, Blum MJ. The relationship between patients' satisfaction with their physicians and perceptions about interventions they desired and received. Medical Care. 27: 1027-35. PMID 2586185 DOI: 10.1097/00005650-198911000-00004  0.062
2022 Parikh RB, Hasler JS, Zhang Y, Liu M, Chivers C, Ferrell W, Gabriel PE, Lerman C, Bekelman JE, Chen J. Development of Machine Learning Algorithms Incorporating Electronic Health Record Data, Patient-Reported Outcomes, or Both to Predict Mortality for Outpatients With Cancer. Jco Clinical Cancer Informatics. 6: e2200073. PMID 36480775 DOI: 10.1200/CCI.22.00073  0.061
2021 Lee S, Yu LQ, Lerman C, Kable JW. Subjective value, not a gridlike code, describes neural activity in ventromedial prefrontal cortex during value-based decision-making. Neuroimage. 118159. PMID 33991700 DOI: 10.1016/j.neuroimage.2021.118159  0.058
1989 Lerman CE, Brody DS, Hui T, Lazaro C, Smith DG, Blum MJ. The white-coat hypertension response: prevalence and predictors. Journal of General Internal Medicine. 4: 226-31. PMID 2786060 DOI: 10.1007/BF02599528  0.05
1989 Lerman CE. The practice of clinical health psychology Clinical Psychology Review. 9: 144. DOI: 10.1016/0272-7358(89)90055-X  0.039
1990 Lerman CE, Brody DS, Hui T, Lazaro C, Smith DG, Wolfson HG. Identifying hypertensive patients with elevated systolic workplace blood pressures. American Journal of Hypertension. 3: 544-8. PMID 2363893 DOI: 10.1093/ajh/3.7.544  0.038
2022 Balfour DJK, Benowitz NL, Colby SM, Hatsukami DK, Lando HA, Leischow SJ, Lerman C, Mermelstein RJ, Niaura R, Perkins KA, Pomerleau OF, Rigotti NA, Swan GE, Warner KE, West R. Balfour et al. Respond. American Journal of Public Health. 112: e2-e3. PMID 34936419 DOI: 10.2105/AJPH.2021.306555  0.015
2022 Balfour DJK, Benowitz NL, Colby SM, Hatsukami DK, Lando HA, Leischow SJ, Lerman C, Mermelstein RJ, Niaura R, Perkins KA, Pomerleau OF, Rigotti NA, Swan GE, Warner KE, West R. Balfour et al. Respond. American Journal of Public Health. 112: e5-e6. PMID 34936414 DOI: 10.2105/AJPH.2021.306570  0.015
Hide low-probability matches.